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Abstract 
The emerging era of personalized medicine relies on medical decisions, practices, and 
products being tailored to the individual patient. Point-of-care systems, at the heart of this 
model, play two important roles. First, they are required for identifying subjects for optimal 
therapies based on their genetic make-up and epigenetic profile. Second, they will be used 
for assessing the progression of such therapies. Central to this vision is designing systems 
that, with minimal user-intervention, can transduce complex signals from biosystems in 
complement with clinical information to inform medical decision within point-of-care 
settings. To reach our ultimate goal of developing point-of-care systems and realizing 
personalized medicine, we are taking a multistep systems-level approach towards 
understanding cellular processes and biomolecular profiles, to quantify disease states and 
external interventions.  
The first step is to generate data. In this step we develop necessary tools to enable 
reliable and repeatable set of experiments, to facilitate sensitive characterization of 
biosystems of interest. To this aim, we have developed AC electrokinetic methods within 
microfluidic systems to translate the bioparticles based on their unique electrophysiology. 
Innovative device structures and signaling schemes are essential for sensitive 
characterization of biosystems and deciphering the underlying mechanism responsible for 
emergent behavior of these systems. To accomplish our goals in this step, we have 
designed relevant device structures or signaling schemes to generate data. In the first 
chapter, we presented a nano-slit structure to create conductivity gradients. These 
patterned conductivity gradients are used to enhance dielectrophoretic trapping of 
nanometer sized proteins, antibodies and antigens to enable and enhance discovery of rare 
cancer biomarkers in high conductivity physiological media. Similarly in Chapter Two we 
employ AC dielectrophoresis inside an insulator based microfluidic structure to 
characterize and separate Human Embryonic Kidney (HEK) and Mouse Embryonic 
Fibroblast (MEF) cells, based on their unique mitochondrial morphology and subsequent 
dissimilar electrophysiology. 
The second step is turning data into information. To this end, we develop tools to 
monitor bioparticles and perform accurate measurements on them. These measurements 
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range from tracking bioparticles to quantifying their morphometric measures. Finding 
proper figures to measure and perform accurate measurements is the key factor for 
sensitive characterization of biosystems. To achieve this goal, in chapter one, we develop a 
sensitive methodology to quantify pre-concentration and depletion of different biomarkers 
in micro/nano fluidic systems. The unique characteristics of this methodology are: highly 
reduced measured noise and geometry free analysis capabilities. In Chapter Two, we 
developed MyMiA; an image analysis software to quantify morphometric properties of 
mitochondrial networks. 
The third step is to turn information into insight. In this step, we use our gained 
information in conjunction with the underlying mechanistic knowledge to predict 
cellular/molecular behaviors leading to disease states and drug responses. To this end, we 
benefit from modeling, computation and simulations to better understand the systems of 
interest. To achieve this goal, in Chapter One, mathematical modeling of protein dielectric 
properties along with intense numerical simulations enabled us to design, enhance and 
optimize a biomarker-sensing system, and in chapter two, by using mathematical modeling 
we found the correlation between mitochondrial network properties (connectedness) and 
cells electrophysiological response, which enabled us to speared cells based on the level of 
connectivity in their mitochondrial network in a completely label free manner. Also by 
using morphometric measures from MyMiA and applying supervised learning algorithms, 
we showed cell line and certain proteomic activities in cells could be predicted based on 
their mitochondrial morphology which is of great importance for predicting patient 
outcomes and also developing new studies on cancer cells.  
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Analyzing biomarker profiles in blood 
serum to enable early detection of cancer 
1 
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Selective and rapid enrichment of biomolecules is of great interest for biomarker 
discovery, protein crystallization and in biosensing for speeding assay kinetics and 
reducing signal interferences. The current state of the art is based on DC electrokinetics, 
wherein localized ion depletion at the anodic interface of the microchannel to perm-
selective nanochannel is used to enhance electric fields and the resulting biomarker 
electromigration is balanced against electro-osmosis in the microchannel to cause high 
degrees of biomarker enrichment. However, biomarker enrichment is not selective and the 
levels fall off within physiological media of high conductivity, due to a reduction in both, ion 
concentration polarization and electro-osmosis effects. In the first part of this chapter we 
present an AC electrokinetic methodology for initiating frequency-selective and ultrafast 
enrichment of biomarkers in physiological media. Using AC fields at a critical frequency to 
generate negative dielectrophoresis of the biomarker of interest and an offset DC field to 
initiate ion conductivity gradients due to ion concentration polarization along the cathodic 
interface of the perm-selective region inside a nanoslit channel, we enhance the localized 
field due to ion depletion and the field gradient due to ion accumulation. Since the surface 
charge non-uniformity that causes perm-selectivity is placed inside the nanoslit, the spatial 
extent for biomarker electrophoresis, as well as its localized trapping by negative 
dielectrophoresis is enhanced, thereby enabling ultrafast biomarker enrichment within 
physiological media. 
To maximize the sensitivity in our platform, we used quantitative information on 
the spatial and temporal dynamics of pre-concentration, such as position, extent and time 
towards sensor design for coupling pre-concentration to detection. Current quantification 
methodologies are based on the time evolution of fluorescence signals from biomarkers 
within a statically defined region of interest, which does not offer information on the 
spatial dynamics of pre-concentration and leads to significant errors when the pre-
concentration zone is delocalized or exhibits wide variations in size, shape and position 
over time under the force field. We present a dynamic methodology for quantifying the 
region of interest by using a statistical description of particle distribution across the device 
geometry to determine the intensity thresholds for particle pre-concentration. We applied 
our method to study the delocalized pre-concentration dynamics under an electrokinetic 
force balance driven by negative dielectrophoresis, for aligning the pre-concentration and 
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detection regions of neuropeptide Y, and for quantifying the polarizability dispersion of 
silica nano-colloids with frequency of the alternating .orce field.  
Since proteomic biomarkers of interest to the early diagnosis of diseases and 
infections are present at trace levels versus interfering species, their selective enrichment 
is needed within bio-assays for speeding binding kinetics with receptors and reducing 
signal interferences. In the third part of this chapter we used our platform to enable 
frequency-selective enrichment of nanocolloidal biomolecules, based on the characteristic 
time constant for polarization of their electrical double-layer, since surface conduction in 
their ion cloud depends on colloidal size, shape and surface charge. In this manner, using 
DC-offset AC fields, differences in frequency dispersion for negative dielectrophoresis are 
balanced against electrophoresis in a nanoslit channel to enable the selective enrichment of 
prostate specific antigen (PSA) versus anti-mouse immunoglobulin antibodies that cause 
signal interferences to immunoassays. Through coupling enrichment to capture by 
receptors on graphene-modified surfaces, we demonstrate the elimination of false positives 
caused by anti-mouse immunoglobulin antibodies to the PSA immunoassay. 
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1.1. Surface conduction enhanced dielectrophoresis in nanoslits for 
rapid and selective biomarker enrichment in physiological media 
Introduction  
Biomarker discovery requires the identification of variations in rare sets of 
biomolecules within bio-fluids that also contain common interfering species, such as 
circulating antibodies, at million to billion-fold higher levels. Hence, there is a need for 
methods to cause rapid and selective enrichment of rare biomarkers versus the interfering 
species[1], preferably within physiological media, to maintain their ability to selectively 
bind with receptors, without needing buffer changes that lead to dilution. Since affinity 
methods based on antibody depletion can cause enrichment levels of no more than two to 
three orders of magnitude[2]; there is a need for complementary enrichment modalities. A 
selectively enriched plug of the target analyte is especially of interest within heterogeneous 
immunoassays for speeding binding kinetics to receptors due to the prevalence of mass 
transport limitations at detection limit target levels[3], while also reducing signal 
interferences from circulating antibodies that bind to the receptors to often cause false 
positives and false negatives[4]. In this manner, immunoassay signals at detection limit 
levels can reach their saturation signal at earlier time points[5], thereby leading to reduced 
errors for analyte quantification, due to the invariance of signals with incubation time and 
method[6]. 
 A commonly investigated methodology for achieving highly enriched analyte plugs 
from dilute samples is through applying an electrokinetic force balance in conjunction with 
localized ion depletion to create a trap due to the sharp spatial profile in the field. Typically, 
ion concentration polarization (ICP) effects at the entrance of perm-selective nanochannels 
are used to cause sharp field gradients due to ion depletion at the anodic interface of 
microchannel to the nanochannel, and this is balanced against electro-osmosis within the 
microchannel[7] to cause high degrees of biomarker enrichment[8]. However, due to the 
abrupt field profile, the trapped biomarkers are co-localized within a tightly confined 
region, which limits the scope for spatially graded stacking towards selectivity. 
Furthermore, the degree of biomarker enrichment obtained by this method can fall sharply 
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within physiological media of high conductivity, due to a reduction in electro-osmosis, as 
well as ICP effects. While a limited degree of biomarker enrichment can be obtained within 
conductive media through utilizing tighter nanochannels and/or higher applied fields to 
enhance ICP, these strategies are not practical due to fabrication challenges, disruptive 
electrothermal flow due to Joule heating and electrical-double layer induced field 
screening. 
 An alternate strategy is to carry out biomarker enrichment under the field profile 
due to ion conductivity gradients inside a nanoslit channel, where surface conduction 
effects are more pronounced than those at the microchannel interface to the nanoslit. 
Hence, the field gradient can be extended along the nanoslit length for enhancing the 
spatial extent of biomarker depletion, in parallel to enabling spatially graded biomarker 
stacking. In prior work, this ion conductivity gradient was created inside the nanochannel 
by connecting it to microchannels loaded with buffers with a high and low conductivity 
media, so that the field profile can be modulated due to electro-osmosis in the 
nanochannel[9], to achieve biomarker enrichment[10]. In this current work, we implement 
a similar electrokinetic force balance in conjunction with ion conductivity gradients 
generated inside a nanoslit channel, rather than in a microchannel. However, the ion 
conductivity gradients inside the nanoslit are initiated by ICP effects created using lateral 
constrictions with large surface charge non-uniformities, so that DC field-induced surface 
conduction continues to be significant versus bulk conduction, even in physiological media. 
Furthermore, instead of electroosmosis as the opposing force field, we utilize AC fields for 
frequency-selective negative dielectrophoresis (nDEP) at the constriction tips, since nDEP 
continues to be a significant force field within media of high conductivity. In this manner, 
we utilize ICP effects to enhance biomarker electrophoresis (EP) and nDEP trapping, 
thereby enabling the net force balance to cause ultrafast biomarker enrichment within 
physiological media.  
 Dielectrophoresis (DEP) enables highly selective trapping of bio-particles based on 
the characteristic frequency response of dielectric permittivity of the particle versus the 
medium[11],[12],[13],[14] for causing frequency-selective enrichment of target 
DNA[15],[16],[17] and protein molecules in physiological media[18],[19], [20], [21],[22]. 
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However, the highly localized nature of DEP behavior, due to its dependence on E2, limits 
its spatial extent[14],[23]. Herein, utilizing ICP effects at lateral constrictions to generate 
conductivity differences along the cathodic region of the perm-selective interface, the 
localized field (E) is enhanced due to ion depletion in the vicinity of the constriction tips, 
whereas ion accumulation along the constriction sidewalls increases the field gradient 
(E), thereby dramatically enhancing the magnitude and spatial extent of nDEP, due to its 
E2 dependence. While our prior work attributed the enhanced biomarker enrichment in 
this device to tilting of the nDEP potential barrier under DC bias; herein, we elucidate the 
role of surface conduction in the nanoslit towards creating ion conductivity gradients that 
enhance the height and depth of the potential barrier for trapping, thereby exponentially 
enhancing localized biomarker numbers due to its Boltzmann distribution profile. 
Furthermore, while ICP effects have been extensively applied within prior work to cause 
ion gradients in the microchannel region interfacing the nanochannel, this is the first report 
on using ICP to initiate ion conductivity gradients inside the nanochannel, where surface 
charge-induced conduction effects can cause more pronounced ICP effects than within 
microchannels. As a result, the presented AC electrokinetic method can cause biomarker 
enrichment within physiological media of high conductivity and with the necessary 
frequency-selectivity to reduce signal interferences during biomarker detection, whereas 
these are not possible with DC electrokinetic methods coupled to ICP. 
Results and Discussion 
A. Device Geometry for ICP-enhanced nDEP enrichment 
We begin with schematically illustrating the mechanism for generating ion conductivity 
gradients inside the nanoslit and illustrate its application towards enhancing the 
electrokinetic enrichment of biomarkers. The device geometry is subsequently optimized 
using the Poisson-Nernst-Plank (PNP) model to simulate the conductivity gradients and its 
application towards frequency-selective biomarker enrichment is validated using spatio-
temporal profiles of fluorescently-labeled streptavidin and prostate specific antigen (PSA). 
Our prior work has implemented this methodology within various sensing paradigms for 
improving biomarker sensitivity [20],[24]. A cross-section view of the device geometry 
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used within this work is schematically presented in Figure 1a, wherein glassy carbon 
modified Pt electrodes within the reservoirs leading to a microchannel on each side are 
used to initiate the discussed electrokinetic effects under a DC-offset (2 V/cm) AC field (70 
Vrms/cm), that is set at the critical frequency required to cause optimal biomarker nDEP, 
which is 1 MHz for streptavidin, 3 MHz for Neuropeptide Y (NPY) [20] and 4-6 MHz for 
Prostate Specific Antigen (PSA)[25]. The microchannels (5 µm depth) are connected by slit-
shaped channels of 200 nm depth (henceforth called nanoslit). Within each nanoslit (300 
µm length / 200 nm depth), a lateral constriction (optimized at 300 nm length and 40 nm 
gap) with a sharp surface charge non-uniformity is used to initiate ICP (see magnified top-
view in Figure 1b), whereas no significant ICP occurs at the micro/ nanochannel interface 
due to the wide nanoslit entry points (30 µm width). The geometry of this constricted 
perm-selective region is designed so as to enable ion conductivity gradients over a wide 
extent across its cathodic interface, due to interaction of ion depletion and ion 
accumulation profiles under field-induced ICP conditions. First, the spatial extent of the 
constriction is designed to be short (l~300 nm) to reduce the length over which the voltage 
drop occurs inside the perm-selective region, thereby enhancing the localized field and 
extending ion depletion through a significant portion of the nanoslit, beyond the immediate 
perm-selective region. In this manner, due to enhanced surface conduction of counter-ions 
and the exclusion of co-ions in the perm-selective region, the ion depletion region extends 
from across the anodic interface through inside of the perm-selective region, up to portions 
across the cathodic interface inside the nanoslit, as reported within other similar 
geometries[26]. Second, the sloping constriction geometry enables a sharp drop in the field 
profile along its sidewall directions versus a more gradual drop along the device centerline. 
As a result, ion accumulation at its cathodic interface is higher along the constriction 
sidewall directions and occurs within a short distance of the constriction tip, whereas the 
accumulation is lower along the device centerline direction and is pushed further away 
from the constriction tip. Due to current conservation, these ion conductivity gradients at 
the cathodic interface modify the localized field and nDEP trapping potential profiles. On 
one hand, the reduction in localized ion conductivity at the constriction tip due to the 
extension of ion depletion across from the anodic to the cathodic interface (depletion), 
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increases the field at the constriction tip: E. On the other hand, the sharp rise in localized 
ion conductivity along the sidewall directions due to the ion accumulation (acc), creates a 
localized reduction in the field away from the constriction tip, thereby increasing the field 
gradient: E. In Figure 1c, we represent these field profile changes in terms of alterations 
in the nDEP trapping potential profile, from the green solid line (nDEP with no ICP due to 
low DC field) to the blue dashed line (nDEP with ICP due to a critical DC field). Since nDEP 
depends on the product of the field and its gradient, its enhancement under these ICP 
conditions can be represented as a higher potential barrier to indicate the higher field at 
the constriction tips and a deeper potential well to indicate the steeper field gradient along 
the constriction sidewall. Hence, biomarker numbers (n) rise with the potential (U) as per 
the Boltzmann distribution: n=noexp(-U/kBT); thereby causing exponential biomarker 
enrichment with an increase in U. 
Furthermore, as a consequence of the extension in ion depletion along the cathodic 
interface to well beyond the immediate vicinity of the perm-selective region, the local ion 
conductivity along the centerline direction (centerline) remains low over an extended length 
away from the constriction tip. Hence, due to current conservation, the field enhancement 
arising from ion depletion at the constriction tips is extended along the centerline direction 
at the cathodic interface, whereas this field enhancement is abruptly lowered along the 
sidewall directions, due to ion accumulation within a short distance of the constriction tip. 
As a result, electrophoresis (EP) is enhanced along the centerline, whereas the nDEP 
trapping is enhanced along the sidewall in the vicinity of the constriction tip, thereby 
routing biomarkers from the off-sidewall directions towards localized nDEP traps at the 
constriction sidewall. In the absence of ICP effects, such as by using AC fields with a DC field 
that is not sufficient to create ICP, we would still have biomarker enrichment along the 
cathodic interface due to the balance of nDEP versus electrophoresis. However, in the 
presence of a critical DC field to cause ICP, the enhanced EP velocities and nDEP trapping 
alters the net potential profile to exponentially enhance biomarker enrichment due to its 
Boltzmann distribution. 
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FIG. 1. (a) Cross-section view of the nanoslit device. (b) Top-view of the lateral constriction used to initiate 
ICP in the nanoslit (biomarkers shown as green particles). (c) alteration of electrokinetic trapping potential 
profile due to ICP enables exponential enhancement in biomarker numbers. The H-shaped ICP device from 
prior work: (d) top-view (e) cross-section. (f) Comparison of calculated surface to total ion current away from 
the perm-selective interface for the different geometries. 
B. Comparison to DC electrokinetics at micro/nano interfaces 
It is noteworthy to compare the current device geometry (Figure 1a), which enables 
the initiation of ICP effects inside the nanoslit channel, to the commonly used H-shaped 
device geometry (Figure 1d and 1e), where ion depletion due to ICP at the microchannel 
interface to nanochannel enhances the local field (by factor 1) for biomarker 
electrophoresis (FEP) versus electro-osmosis (FEO), as given by the force balance: 
𝐹𝑛𝑒𝑡 = 𝛼1𝐹𝐸𝑃 − 𝐹𝐸𝑂          (1) 
With increasing media conductivity (m), the increasing competition of bulk 
conduction with surface conduction in the nanochannel causes the level of ICP 
enhancement (1) to drop, whereas the less thick electrical double-layer causes FEO to drop, 
thereby reducing the net level of biomarker enrichment (Fnet). On the other hand, in the 
geometry of Figure 1a, by initiating ICP inside the nanoslit rather within the interfacing 
microchannel, we seek to maintain a significant level of ICP (which enhances FEP and FnDEP 
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by factors of by 2 and h, respectively. Even within conductive physiological media, due to 
the strong influence of the surface charge non-uniformity (c) in the nanoslit on enhancing 
surface conduction over bulk conduction. With the H-shaped device geometry, on the other 
hand, ICP effects in the microchannel are less influenced by the surface charge non-
uniformity created by the nanochannel / microchannel interface. This comparison of the 
influence of 1 versus that of 2 is shown in Figure 1f, in terms of the calculated surface to 
total ion current away from the perm-selective interface. For the device geometry of Fig. 1a, 
ICP due to the constriction-induced surface charge non-uniformity in the nanoslit enables 
an enhancement (due to 2) in surface conduction over an extent of 20 nm from the perm-
selective interface, with only a gradual fall off over the next 80 nm to a steady enhanced 
level through the rest of the nanoslit channel length. In comparison, at the H-shaped device 
geometry, while the surface conduction effects are strong at the microchannel interface to 
the nanochannel due to the sharp field profile, this surface conduction drops off sharply 
within a few nanometers from the perm-selective interface into the microchannel, since the 
nanochannel surface charge presents a less weak influence on ion conduction within the 
microchannel. As a result, in order to maintain a significant degree of ion depletion within 
conductive physiological media, due to ICP at the microchannel to nanochannel interface, 
there is a need for tighter nanochannels and/or higher applied fields to enhance ICP 
conditions (or 1). These strategies are not practical due to fabrication challenges, 
disruptions from Joule heating induced electrothermal flow and voltage drop due to field 
screening by the electrical-double layer. A second major difference between these two ICP-
based electrokinetic biomarker enrichment methods arises from how the ICP is utilized. 
Within the H-shaped device geometry, while ICP at the sharp microchannel to nanochannel 
interface creates a region with ion depletion at the anodic interface and ion accumulation 
at the cathodic interface, these ion depletion and accumulation regions do not interact due 
to their spatial separation. In fact, a spatial separation of at least 300 m is required, 
especially within media of successively higher levels of conductivity, to prevent co-ion 
leakage from the cathodic to anodic portion of the microchannel / nanochannel interface, 
since this leakage will reduce the level of depletion along the anodic interface. Due to this 
spatial separation, only the localized ion depletion at the anodic interface is used to 
 16 
enhance the fields for DC-based electrokinetic enrichment, thereby creating sharp field 
gradients, with no ability to spatially modulate the field profile. Within our constriction-
based nanoslit device geometry, on the other hand, the proximity of the ion depletion and 
ion accumulation regions cause their interaction, so that both regions act together to 
modulate the field profiles and create localized traps for enhancing the spatial extent of 
biomarker trapping. In fact, to maximize the voltage drop across the perm-selective region 
for enabling higher localized fields, we prefer designs with a short perm-selective spatial 
extent (usually 300 nm), so that it is just sufficient to maintain ion depletion along the 
cathodic interface. The third distinguishing feature of our approach is that instead of an 
opposing electroosmotic force field, we utilize AC fields to initiate frequency-selective 
nDEP away from the constriction tips, since nDEP continues to be a significant force field 
even within media of high conductivity. This is apparent considering the force balance at 
the cathodic interface in Figure 1a: 
𝐹𝑛𝑒𝑡 = 𝛼2𝐹𝐸𝑃 − 𝛽𝐹𝑛𝐷𝐸𝑃 − 𝐹𝐸𝑂         (2) 
Hence, at higher m, the drop in ICP-induced enhancement (2 & ) can be arrested by 
using a sharper surface charge non-uniformity (c~0.08-0.3 C/m2) in the nanoslit, for 
enabling sufficient surface conduction versus increasing bulk conduction (Figure 1f). 
Furthermore, by using an opposing nDEP force field, a higher level of FnDEP in Eq. 2 is 
maintained at high m, due to its dependence on the difference of particle versus medium 
conductivity: (p-m). In this manner, we continue to enhance the net biomarker transport 
towards the cathodic interface for biomarker enrichment within physiological media, since: 
(a) ICP effects that drop off within conductive media (lower  & ) continue to be 
significant within our device geometry, due to the significant role of surface conduction 
inside the nanoslit arising from the large surface charge non-uniformity of the lateral 
constriction (c), and: (b) nDEP effects rise rather than fall within conductive media, 
thereby maintaining a localized opposing force balance. In the subsequent sections, we 
compute the ion conductivity profiles to optimize the device geometry for enhanced 
biomarker trapping, and experimentally validating these ion conductivity gradients by 
mapping spatio-temporal biomarker trapping profiles under various applied field 
magnitude, frequency and bulk media conductivity conditions. 
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C. Optimizing device geometry for enhancing nDEP 
     We consider optimization of the geometry of the perm-selective region within the 
nanoslit for enhancing electrokinetic biomarker enrichment under ICP conditions. 
Specifically, we compute ICP-induced ion conductivity profiles along the constriction 
sidewall and centerline directions, for varying lengths (l) and widths (d) of the perm-
selective region, thereby enabling an assessment of the ensuing enhancement in nDEP. The 
angle of lateral constriction in the nanoslit is held constant at 30 to enable the highest 
possible field gradient (|E|), under the fabrication limitations. Due to the |E|2 
dependence of nDEP, we seek device geometries that promote ion depletion at the 
constriction tip to enhance the field (E) and initiate ion accumulation along the constriction 
sidewall to enhance the field gradient (|E|). Since the ion conductivity profiles in Figure 2 
are computed in media with bulk conductivity of 1 S/m, the regions with localized 
conductivity less than 1 S/m exhibit ion depletion and those at greater than 1 S/m exhibit 
ion accumulation, with the insets (i-iv) indicating the respective region of counter-ion 
accumulation (solid orange circles). For the case of a perm-selective region with a large 
length (3000 nm), the surface charge non-uniformity has a greater electrostatic interaction 
length with counter-ions undergoing surface conduction. This will limit the level of surface 
conduction of counter-ions out of the perm-selective region, thereby causing counter-ion 
accumulation inside the perm-selective region, including at the constriction tips. As a 
result, the degree of ion depletion inside the perm-selective region is reduced, thereby 
limiting the degree of field enhancement at the constriction tip along the cathodic interface. 
The computed ion conductivity profile in Figure 2a for this case (3000 nm length of perm-
selective region) shows no apparent ion depletion, with only a maximum in ion 
accumulation that occurs right at the constriction tips, as per inset (iv). For successively 
smaller length extents of the perm-selective region, the higher localized field and lower 
electrostatic interaction length with counter-ions enhances the net surface conduction. As a 
result, ion depletion at the constriction tips is enhanced (Figure 2a, inset v) to cause further 
increases in the localized field (E). However, the level of ion accumulation along the 
sidewall direction is seen to gradually decrease with increasing perm-selective extent, 
thereby lowering the field gradient (|E|), with the peak region for ion accumulation being 
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pushed further away from the constriction tip along the sidewall. This suggests that an 
optimal length extent of the perm-selective region is needed for maximum electrokinetic 
enhancement, due to its |E|2 dependence. Hence, we compute an optimal perm-selective 
length for surface conduction enhanced nDEP (factor “h” in Eq. 2), based on the product of 
the rise in potential energy barrier height due to field enhancement (E) under ion depletion 
(by factor: ) and the deeper potential well due to field gradient (|E|) under ion 
accumulation (by factor: ).  
 
FIG. 2. (a) Ion conductivity profile along the constriction sidewall for different perm-selective lengths (gap 
width: 40nm) within media of bulk conductivity of 1 S/m. Insets  (i-iv) show schematic of counter-ion 
distribution for different perm-selective lengths and (v) shows a magnified view of the depletion for each 
perm-selective length. (b) Ion conductivity profile along the constriction sidewall for different perm-selective 
gap widths (length: 300nm) at medium conductivity of 1 S/m. Inset (vi) shows a magnified view of the 
depletion at each constriction gap and inset (vii) shows ion conductivity profile along the constriction 
centerline for perm-selective region with 40nm width and 300 nm length with media of bulk conductivity of 1 
S/m. (c) Calculated electrokinetic enhancement due to ICP for different perm-selective lengths (solid blue 
line) and gap sizes (dashed red line). 
It is apparent from the plot in Figure 2c that a perm-selective region with a length of 
300 nm is optimal, since it is capable of causing ~8-fold level of electrokinetic trapping 
enhancement (factor “h” in Eq. 2) at bulk media conductivity of 1 S/m to cause 
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exponentially higher biomarker numbers (ehU) versus that for nDEP with no ICP. At a 
smaller length of the perm-selective region (200 nm), while the degree of ion depletion is 
higher at the constriction tips (increasing E), the ion accumulation is lower and occurs too 
far away from the constriction tip to cause the necessary rise in E2, for enhancing ICP-
induced trapping. On the other hand, with gradual lowering of the constricting perm-
selective gap, the enhanced exclusion of co-ions and surface conduction of counter-ions 
causes a higher level of ion depletion (Figure 2b, inset vi), as well as ion accumulation.  
This explains the monotonic rise in the net electrokinetic enhancement in Figure 2c, for 
gaps varying from 160 nm to 40 nm. Finally, we compare the ion conductivity profile along 
sidewall (Figure 2b) versus centerline directions (Figure 2b, inset vii). For the optimal 
perm-selective device geometry to enhance electrokinetic enrichment (40 nm constriction 
gap with a 300 nm length extent), the centerline direction undergoes ion depletion over a 
wide extent (~7.5 m from constriction tip), with more modest levels of ion accumulation 
thereafter, whereas the ion depletion region along the sidewall direction is localized within 
0.5 m from the constriction tip, followed by strong levels of ion accumulation. This 
quantitative picture is consistent with the schematic ion conductivity profiles, shown 
earlier in Figure 1b to explain the enrichment mechanism.  
C. Dimensionless perm-selectivity factor for AC electrokinetic enhancement 
A critical level of perm-selectivity is required to initiate the necessary ion conductivity 
gradients that arise due to spatially proximal ion depletion and ion accumulation regions, 
for enhancing the net electrokinetic enrichment. We describe the necessary perm-selective 
geometry by the following dimensionless analysis. The necessary perm-selectivity (PS) 
depends on the perm-selective gap length (l), its cross-sectional area (A: product of gap 
width to nanoslit depth), its surface charge distribution (c), the ion mobility () and media 
conductivity (𝜎𝑚). We write this in terms of the following dimensionless parameter: 
𝑃𝑆 =
𝜌𝑐𝜇𝐿
2
𝜎𝑚𝐴
          (3) 
Based on this, critical PS values are in the range(6 × 10−9 to 6 × 10−6). Unlike the case 
of DC electrokinetics, where maximum levels of perm-selectivity are needed, as achieved 
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through reducing perm-selective gap (to reduce A) or increase length (L) to exponentially 
increase PS, we prefer PS values inside this range. For PS values above: 6 × 10−6; ion 
accumulation and depletion are too far spatially separated, so that accumulation occurs 
only on the cathodic side and depletion occurs only on the anodic side. Such wide spatial 
separation of the ion accumulation and depletion regions coupled to ion accumulation at 
the cathodic side where trapping occurs under nDEP, reduces the electric field and their 
gradients, thereby reducing the net nDEP trapping efficiency. On the other hand, at PS 
values less than 6 × 10−9, ICP effects are not present, thereby causing no enhancement in 
nDEP trapping due to ICP.  
D. Influence of bulk media conductivity 
Conductivity of the bulk media (m) determines the electrical double-layer (EDL) 
thickness within the perm-selective region (schematically shown within insets (i-iii) in 
Figure 3a), so that the ensuing differences in surface conduction strongly influence the ion 
conductivity profiles along the cathodic interface of the constriction. At lower bulk media 
conductivities (m=0.2 S/m), the thicker EDL causes enhanced levels of co-ion exclusion 
and counter-ion surface conduction within the perm-selective region, which in turn 
enhances the levels of ion depletion and ion accumulation versus those achieved within 
media of higher conductivities (m=1 and 2 S/m). Figure 3 presents this information in 
terms of the normalized conductivity; i.e. as a ratio of the local conductivity to the bulk 
conductivity, with ion depletion in regions below unity and ion accumulation in regions 
above unity. Comparing Figure 3a and Figure 3b, it is clear that the degree of ion 
accumulation is significantly greater along the sidewall direction versus the centerline, and 
it peaks at well less than 0.5 m from the constriction tip. Along the centerline direction, on 
the other hand, the effects of ion depletion from the perm-selective region continue to be 
apparent over several microns from the constriction tip, with the peak in ion accumulation 
occurring much further along, thereby creating a wide region for the localized ion 
conductivity gradient along the cathodic interface. These results are consistent with the 
schematic in Figure 1b, showing ion depletion over a broad elliptical region along the off-
sidewall directions and ion accumulation close to the sidewall directions.  
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FIG. 3. Normalized ion conductivity profile for different bulk media conductivities (Perm-selective length of 
300 nm and gap width of 40nm): (a) along the constriction sidewall, and (b) along the constriction centerline.  
Insets (i-iii) show a schematic of how the electrical double layer affects the counter-ion distribution, inset (iv) 
shows the net electrokinetic enhancement due to ICP effects within media of different bulk conductivities 
(neglecting electro-osmosis), and inset (v) shows the alteration of the extent of ion depletion when electro-
osmosis effects are considered at m of 0.2 S/m. 
At m of 1 S/m, there is no ion depletion beyond the constriction tip along the sidewall 
directions and ion accumulation peaks within 0.4 m from the constriction tip, whereas 
along the centerline direction, the ion depletion extends to ~5 m from the constriction tip 
and the localized conductivity gradient due to differential ion accumulation extends ~13 
m. As a result, the computed enhancement in potential barrier for trapping due to ion 
conductivity gradients at m of 1 S/m, continues to be significant in Figure 3c (~8-fold 
enhancement, with a conservative c: 0.08 C/m2), even though the EDL is not thick enough 
to ensure maximum co-ion exclusion and counter-ion surface conduction within the perm-
selective region versus the respective level at m of 0.2 S/m. However, while electro-
osmotic effects on ion migration can be neglected at higher m ( 1 S/m), since 
electrophoretic ion mobilities are significantly greater than electro-osmotic mobilities in 
nanochannels[27],[28],[29] (see Supporting Information), this is not the case at m of 0.2 
S/m, where the two mobilities are comparable[30]. The inset (v) of Fig. 3b shows the effect 
of including electro-osmosis at m of 0.2 S/m, on the localized ion conductivity profiles. 
While the ion depletion region extends over a significant portion of the device centerline in 
the absence of disruptions from electro-osmotic flow (~5 m and ~8 m from constriction 
tip at 1 S/m and 0.2 S/m, respectively), it is significantly reduced due to disruptions from 
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electro-osmotic flow at m of 0.2 S/m (down to ~1.5 m). We attribute this lowering of ion 
depletion along the cathodic interface at m of 0.2 S/m to the reduced co-ion leakage from 
the cathodic to anodic interface due to greater levels of co-ion exclusion at lower m and 
the opposing influence of electro-osmotic flow. Hence, the degree of biomarker enrichment 
at lower m is likely to be less optimal due to greater opposing electro-osmotic flow and 
lower localized nDEP trapping (see Eq. 2), which suggests a more dispersed biomarker 
trapping profile with lowering m, as validated subsequently. Assuming a Boltzmann 
distribution for biomarkers, the ~5-fold enhanced potential barrier for electrokinetic 
trapping under ICP at m of 1.6 S/m using a conservative estimate for the surface charge 
non-uniformity (c: 0.08 C/m2) in Fig. 3a (iv), suggests >100x higher levels of 
preconcentration (ehU) than obtained solely under nDEP and up to 25-fold reduction in 
biomarker accumulation times. 
E. Validation using spatio-temporal biomarker profiles 
In order to explain how these conductivity gradients along the cathodic interface of the 
constriction region influence the profile and level of electrokinetic biomarker enrichment, 
we present spatio-temporal images and temporal plots of enrichment of labeled 
streptavidin at 1 MHz in Figure 4 (a-k), from a starting level of 100 ng/mL. Furthermore, to 
illustrate the frequency selectivity offered by this method, we identify conditions for 
enrichment of PSA versus interfering antibodies (Figure 4l). 
The fluorescence intensity versus time plots for various conditions of nDEP induced 
electrokinetic trapping are determined by averaging the maximum intensities from 20 
pixels along the sidewall direction and normalizing these fluorescence levels to those 
obtained under purely DC fields, where no perceptible rise in fluorescence is apparent. For 
comparison, we choose the following: (1) trapping within constriction gaps of varying size: 
~ 40 nm in Figure 4a-4c versus ~130 nm in Figure 4f-4h; (2) trapping under varying 
degrees of surface conduction for inducing ICP conditions, using a critical DC offset field 
(1.5 VDC/cm) to enhance ICP in Figure 4c versus a sub-critical DC offset field (0.2 VDC/cm) 
to obviate ICP conditions in Figure 4e; and (3) trapping within physiological media, using 
PBS buffers with m of 1.6 S/m versus 10-fold diluted PBS buffers with m of 0.2 S/m 
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(Figure 4b versus Figure 4j, after 1s trapping). For nanoslits with 40 nm constrictions 
(Figure 4a-4c), within 0.3s of field application, a significant level of biomarker 
preconcentration is apparent along the constriction sidewall within 0.3 m of the 
constriction tip and biomarker depletion over a broad elliptical region that extends ~20 
m along the centerline is also clear. Over time, the biomarker depletion region remains 
more-or-less unchanged, while biomarker preconcentration gradually extends from the 
constriction sidewall directions to cover the off-sidewall directions. For the case of 
nanoslits with 130 nm constrictions, the profiles are somewhat similar (Figure 4f-4h), with 
initial preconcentration along constriction sidewalls and a biomarker depletion region 
along the centerline. However, the preconcentration is considerably slower[31], as 
apparent from the longer time intervals, and the biomarker depletion region extends no 
more than ~3 m along the centerline. For the case of trapping under nDEP conditions 
with a sub-critical DC field for initiating ICP, the biomarker enrichment rate is gradual 
(Figure 4k) and the trapping profile shows only a very small biomarker depletion region 
(~0.3 m along centerline in Figure 4e). 
Within 10-fold diluted PBS media (m~0.2 S/m), the trapping is dispersed, with no 
biomarker depletion region, even with a critical DC field for initiating ICP alongside nDEP. 
These enrichment profiles under various field, media conductivity and device geometries 
validate the role of m gradients generated under ICP conditions along the cathodic 
interface of the constriction region inside the nanoslit (as described in Figure 2 and Figure 
3). As per the schematic in Figure 4d depicting biomarker and ion transport in nanoslits 
with constrictions of 40 nm gap, the high field due to ion depletion near the constriction tip 
and the high field gradient due to ion accumulation along the constriction sidewall cause a 
localized nDEP trap (green arrows) within ~0.3 m from the constriction tip along the 
sidewall, which correlates with region of maximum biomarker in Figure 4a-4c. 
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FIG. 4. Fluorescence images of streptavidin preconcentration in physiological media (m ~1.6 S/m) from a 
starting level of 100 ng/mL, under an electrokinetic force balance due to 70 Vrms/cm (AC) plus 1.5 VDC/cm 
offset for: (a) t=0.3s, (b) t=1s, (c) t=3s of enrichment at nanoslits with 40nm constriction gap widths and (f) 
t=5s, (g) t=10s, (h) t=20s of enrichment at nanoslits with 130nm constriction gap widths. (d) 
Preconcentration under predominantly nDEP conditions (no ICP enhancement) after 20 s of enrichment; and 
(j) preconcentration under conditions similar to (a-c), but in media of 10-fold lower conductivity (m~0.2 
S/m). A schematic explanation of the biomarker preconcentration profile under the force balance of 
electrophoresis (red) vs. nDEP (Green) and enhanced second order electroosmosis (orange) is shown for: (d) 
physiological media, and (i) 10-fold diluted media. (k) Fluorescence intensity versus time averaged for 20 
pixels along the constriction sidewall with highest intensity and normalized to fluorescence under purely DC 
fields. (l) Biomarker enrichment versus frequency of applied field (0.8-6 MHz) for streptavidin (light blue), 
PSA (orange) and anti-mouse IgG (green). Blue scale bar = 10 m. 
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On the other hand, the high field along the device centerline arising from extension of 
ion depletion onward from the constriction tip drives biomarkers by electrophoresis (red 
arrows) away from the centerline towards the nDEP trapping region along the sidewall, 
correlating to the broad biomarker depletion region away from the off-sidewall directions 
up towards the device centerline. The localized m gradients due to ICP at bulk m of 1.6 
S/m (Figure 3a (iv)) that cause at least 5-fold enhancement in potential barrier for trapping 
(assuming a conservative c: 0.08 C/m2) suggest >100x higher levels of enrichment than 
obtained solely under nDEP. As per the fluorescence levels in Figure 5k, this causes 
localized enhancement of >5000x in streptavidin concentration. In fact, our prior work 
quantified this at 104-105-fold concentration enhancement in the preconcentration region 
and ~103-fold enhancement in analyte binding at capture probe surface[20]. This is 
apparent from the sharp rise in fluorescence signal to saturation levels in Figure 5k, within 
just 3 seconds (curve (i)). For the nanoslit with a constriction of 130 nm gap (Figure 4f-4h), 
the biomarker enrichment profile is quite similar to that for the equivalent device at 40 nm, 
but the lower level of nDEP trapping, as well as the ICP enhancement of electrokinetic 
trapping due to lower ion depletion levels cause a less sharp rise in fluorescence signal 
versus time (Figure 4k, curve (ii)) and smaller region of biomarker depletion. It is 
noteworthy that ICP-enhanced nDEP trapping with a 130 nm constriction gap is greater 
than that obtained under nDEP trapping conditions at a 40 nm constriction gap, with no 
significant ICP enhancement (Figure 4k, curve (ii) vs. (iii)). This suggests that nDEP 
trapping within nanoslits containing larger constriction gaps (~130 nm) can be enhanced 
over that obtained utilizing smaller constriction gaps (~40 nm), by sufficiently increasing 
DC offset field to enhance surface conduction for inducing ICP. Within media of lower bulk 
conductivity (10-fold diluted PBS media at m~0.2 S/m), the highly dispersed biomarker 
enrichment along the entire cathodic interface (Figure 4j) is explained by the schematic in 
Figure 4i. Herein, the force balance is dominated solely by biomarker electrophoresis (red) 
versus electro-osmosis in the nanoslit (orange), with a minimal role for nDEP trapping 
(green), thereby explaining the absence of the biomarker depletion region along the 
centerline and the highly focused biomarker trapping region along the sidewall directions 
that are seen within PBS media. 
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Methods 
A. Theoretical Formulation 
Ion conductivity profiles were computed for perm-selective geometries within the 
nanoslit, assuming constant surface charge non-uniformity (c) through applying Neumann 
flux/source boundary condition as shown in equation 5. We use a conservative estimate of: 
c= −0.08 𝐶𝑚−2, [32], which is well lower than possible higher end estimates (c =
0.3 𝐶𝑚−2).[33] At equilibrium the electric potential, 𝜓, distribution is governed by the 
Poisson equation[34]:  
∇2𝜓 = −
1
𝜀𝑟𝜀0
∑ 𝑧𝑖𝑒𝑛𝑖
𝑁
𝑖=1            (4) 
To solve Poisson equation, Dirichlet boundary condition was applied to inlet/outlet 
walls in reservoirs, where electrodes are inserted, to simulate the voltage source. All other 
boundaries are set to zero flux. In 𝑁𝑎𝐶𝑙 solution, 𝑁 = 2 is the number of ionic species, 
where 𝑛𝑖 (𝑖 = 𝑁𝑎, 𝐶𝑙) and 𝑧𝑖(𝑖 = 𝑁𝑎, 𝐶𝑙)  are the number density and valence of 𝑖
𝑡ℎ ionic 
species respectively. 𝜀0 and 𝜀𝑟 = 80 , represent permittivity of vacuum and relative 
permittivity of the medium, respectively. Using a continuum treatment of the problem, in 
the absence of chemical reactions, the flux of each of these ionic species is described by 
Nernst-Planck equation, which represents the balance between convection, diffusion and 
ionic drift due to presence electric field[32],[35]. 
𝜕𝐶𝑖
𝜕𝑡
= 𝛻. (𝐷𝑖𝛻𝐶𝑖 +
𝐷𝑖𝑒𝑧𝑖𝛻𝜓
𝐾𝐵𝑇
𝑐𝑖 − ?⃗? 𝑐𝑖)           (5) 
With  (𝑖 = 𝑁𝑎 𝑜𝑟 𝐶𝑙) , 𝐷𝑁𝑎 =  1.33 × 10
−9   
𝑚2
𝑠
 and 𝐷𝐶𝑙 = 2.03 × 10
−9 𝑚
2
𝑠
 are the 
diffusion coefficient of ion species, 𝐾𝐵 is Boltzmann constant, 𝑇 is the temperature, 𝑐𝑖 is the 
molar concentration of species at each point of the device and u is the fluid velocity vector. 
To solve this equation, all boundaries except inlet and outlet walls were assigned zero flux 
boundaries for both ionic species. Dirichlet boundary condition equal to bulk concentration 
is assigned to both Inlet/outlet for both ionic species. In steady state, continuity equation 
requires : ∇. 𝐽𝑖 = 0 . A closer examination of equations (3) and (4) reveals their 
interdependence, thereby requiring them to be solved simultaneously. Together they are 
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known as Poisson-Nernst-Plank (PNP) equations, which should be solved numerically, 
since analytical solutions are not available for their nonlinear form[32]. Using standard 
boundary conditions for continuity of: 𝜓 and 𝐶𝑖; and of their first derivatives, we used 
COMSOL Multiphysics to solve these equations over 2D space to find the concentration 
distribution of ionic species at any point in the device.  The only exceptions are at the 
constriction tip and within the walls of the perm-selective region, wherein the electrical 
boundary condition is set to account for the surface charge density (c): 
𝑑𝜓
𝑑𝑟
=
𝜌𝑐
𝜀0𝜀𝑟
             (6) 
Assuming incompressibility of the fluid, ∇. 𝑢 = 0, Navier-Stockes equation, which 
governs the fluid momentum completes these set of equations: 
𝜌𝑚
𝜕𝑢
𝜕𝑡
= −∇𝑝 + 𝜂∇2𝑢 + 𝑓        (7) 
In this equation 𝜌𝑚 = 1000 𝑘𝑔/𝑚
3  is the water density, 𝑝  is the pressure, 𝜂 =
1.002 𝑚𝑃𝑎. 𝑠 is the water dynamic viscosity and 𝑓 is the body force. In the nanoslit design, 
due to the high surface to volume ratio, we can neglect dielectric forces [36], and electric 
body force can be defined as follows, with 𝜌𝑓 , as the free charge density: 
𝑓 = −𝜌𝑓 ∇𝜓             (8) 
To solve for fluid flow, the no-slip Dirichlet boundary condition was applied to walls of 
the microchannel, constriction and perm-selective regions. Along these boundaries, a 
layered quadrilateral mesh with dense element distribution in the normal direction was 
used to resolve the thin boundary layers along the no-slip boundaries. However, for 
simulations in media of bulk conductivity of 1 S/m, the double layer thickness is within 
1% of nano slit depth. Hence, in order to significantly lower computational requirements in 
our set of simulations within the microchannel region, which is very far from perm-
selective zone, Dirichlet electroosmotic velocity boundary condition can be applied to the 
boundaries (walls) through choosing proper electroosmotic mobility for each bulk 
conductivity value.  
After solving equations (4, 5 & 7), the current through any particular cross sectional 
area of the channel can be calculated [37]: 
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𝐼 = ∬(−Λ∇(𝜓 + 𝜙) − 𝐹∑𝑧𝑖𝐷𝑖∇𝑐𝑖 + 𝐹𝑢∑𝑧𝑖𝑐𝑖)                (9) 
Here: Λ = 𝐹2∑𝑧𝑖
2𝑚𝑖𝑐𝑖  is the electrolyte electrical conductivity, 𝑚𝑖  is the electrical 
mobility, 𝑐𝑖 is the molar concentration, 𝜙 is the electrical potential distribution due to the 
external applied voltage, and finally F, is the Faraday’s constant. At steady state, non-
uniform distribution of electric field, E, will cause the particles in the medium to experience 
dielectrophoretic force (FDEP). The average FDEP on a homogeneous spherical particle with 
electrical permittivity 𝜀𝑝, conductivity 𝜎𝑝, and radius, 𝑎, suspended in a fluid with electrical 
permittivity 𝜀𝑚, and conductivity 𝜎𝑚, is given by the following: 
𝐹 𝐷𝐸𝑃 = 2πa
3𝜀𝑚𝑅𝑒 (
𝜀𝑝
∗−𝜀𝑚
∗
𝜀𝑝
∗+2𝜀𝑚
∗ )⏟    
𝐾𝐶𝑀
 𝐸. ∇𝐸 = ξ |𝐸|. ∇|𝐸|          (10) 
KCM is the Clausius–Mossotti factor, which depends on the frequency (𝜔) of the applied 
field as given by: 𝜀𝑝
∗ = 𝜀 − 𝑗𝜎/𝜔. Due to the DC offset of the applied voltage, particles in the 
medium will also experience electrophoresis (𝐹𝐸𝑃), which can be calculated from the 
following equation: 
𝐹𝐸𝑃 = 𝛾𝜇𝐸𝑃𝐸𝐷𝐶           (11) 
Here, 𝜇𝐸𝑃 is electrophoretic mobility, and 𝛾 = 6𝜋𝜂𝑎, is the friction coefficient for a 
spherical particle with radius a in a medium with viscosity of 𝜂. Biomarker trapping occurs 
under electrokinetic force balance of 𝐹𝑛𝐷𝐸𝑃 and 𝐹𝐸𝑃, under a zero net force on the particle, 
𝐹𝑛𝑒𝑡: 
𝐹𝑛𝑒𝑡 = α2(x, y, σ𝑚)𝐹𝐸𝑃 − β(x, y, σ𝑚)𝐹𝐷𝐸𝑃       (12) 
α2(x, y) & β(x, y) denote the respective levels of local ICP-induced enhancement as a 
function of position and medium conductivity. Since all steady-state electrical forces are 
conservative vector fields, we can calculate scalar potential energy fields, to describe the 
net electrokinetic force balance in terms of barriers and wells that affect particle trapping 
within the device. The potential field is given by the integral over the volume (dV) of the net 
electrokinetic force[18]: 
𝑈 = ∮𝐹𝑛𝑒𝑡. 𝑑𝑉          (13) 
This integral in the presence of AC and DC fields is: 
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𝑈 =
ξ𝛽𝐸2
2
− α𝛾𝜇𝐸𝑃. 𝑉𝐷𝐶                           (14) 
𝑉𝐷𝐶 is the offset voltage to enable electrophoresis (EP). 
B. Experimental Methods 
Details of experimental device geometry and operation are available in prior work18-22 
and in Supporting Information. Biomarkers were procured as follows: Alexa 488 labeled 
Streptavidin (~60 kDa) from Molecular Probes (Eugene, OR), Alexa 488 labeled Goat anti-
mouse IgG antibody (~150kDa) from Invitrogen / Thermo Fisher Scientific, and Dylight 
594 labeled Prostate Specific Antigen (~28 kDa) from Sigma Aldrich (St. Louis, MO).   
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1.2.Quantifying spatio-temporal dynamics of biomarker pre-
concentration and depletion in microfluidic systems by intensity 
threshold analysis 
Introduction 
Sensitivity gains from the scale-down of various sensor paradigms can be realized only 
if the ensuing mass transport limitations are alleviated[38], since the slow analyte settling 
and binding kinetics at the sensor surface can substantially delay signal onset at 
micro/nanosensors[5]. Micro/nanofluidic device methodologies are routinely applied 
towards enabling analyte pre-concentration within physiologically relevant media[39-41] 
for reducing target diffusion time towards the sensor[16] and thereby enhancing detection 
sensitivity[42]. Selective pre-concentration also enables analyte enrichment over 
interfering proteins and small molecules[20], which is especially relevant given the wide 
concentration range of proteomic biomarkers within typical biofluids (mg/mL – 
pg/mL)[2]. In order to capitalize on the reduced diffusion lengths towards the sensor upon 
analyte pre-concentration within microfluidic and nanochannel geometries, there is a need 
to effectively overlap the pre-concentration and detection regions for ensuring enhanced 
target binding kinetics at the sensor. We describe herein a methodology for quantifying the 
spatio-temporal dynamics of biomarker preconcentration within microfluidic systems to 
ensure effective alignment of the sensor to pre-concentration within the microfluidic 
device, for guiding device fabrication. 
A variety of force fields are utilized within microfluidics to realize varying degrees of 
pre-concentration, including electrokinetic, chemical, diffusional, inertial, and magnetic 
methods [43, 44]. The degree of pre-concentration is quantified by following the time 
evolution of fluorescence signals from labeled analyte biomarkers as a function of the force 
field driving the enrichment[45], [17]. Quantification of the spatio-temporal dynamics of 
pre-concentration has usually been accomplished by monitoring fluorescence alterations 
over time inside a particular region of interest (ROI), as specified by discrete points[46], 
[47], or along a representative line axis[48],[49], [50], or a statically defined box[51],[52] to 
identify the time and location of the peak intensity. All these prior methods for quantifying 
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pre-concentration have been based on the application of a static ROI. One drawback of 
utilizing such passive methodologies to follow pre-concentration dynamics is the error that 
can be introduced due to exclusion of the full extent of pre-concentration or inclusion of the 
background intensity, thereby leading to underestimation or overestimation of the pre-
concentration degree over time. Furthermore, static ROIs cannot capture the spatial 
dynamics of the pre-concentration zone, such as its extent or rate of growth. Finally, while 
such passive ROIs may be adequate in situations where pre-concentration is highly 
localized, they are not well suited for cases where pre-concentration has a more diffuse or 
delocalized nature, such as is common under a balance of opposing force fields. 
Dielectrophoresis (DEP) enables the frequency-selective translation of polarized 
particles under a spatially non-uniform electric field[12, 14] and is routinely applied 
towards pre-concentration of biomolecules[13, 19, 36]. Positive DEP (pDEP) or particle 
translation towards localized regions of high field causes rapid pre-concentration. 
Quantification of pre-concentration dynamics under pDEP, as presented within prior 
work[53-58] is relatively straightforward due to the spatially localized nature of the pre-
concentration region. Negative DEP (nDEP) or particle translation away from localized high 
field points can also cause rapid pre-concentration when it is applied in conjunction with 
electro-osmosis or electrophoresis[18]. However, since pre-concentration under the 
ensuing electrokinetic force balance is spatially delocalized, there is a need to develop 
methodologies that are based on the pixels over the entire extent of the pre-concentration 
zone, rather than utilizing methods based on pixels within a limited ROI, such as point, line, 
or boxed areas. Furthermore, given the wide variations in pre-concentration extent with 
force fields, there is a need for methodologies to dynamically define the ROI for 
characterizing the pre-concentration dynamics. Finally, since pre-concentration occurs 
chiefly due to the high spatial non-uniformities of the electrokinetic force fields, there is a 
need for criteria to weight each pixel within the pre-concentration zone based on its 
geometric location from the high field points that drive this force field, for accurately 
quantifying the relative particle polarizability and force dispersion dynamics.  
Herein, we present a dynamic methodology for quantifying the pre-concentration 
dynamics of particles under an electrokinetic force balance, driven by nDEP away from 
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insulating constriction tips, which causes a highly delocalized pre-concentration zone. This 
automated methodology for quantifying pre-concentration is based on defining a threshold 
intensity level for dynamic determination of the ROI, through a statistical description of 
particle distribution across the device geometry to enable the quantification of pre-
concentration and depletion signals over the background level. We illustrate the need for 
such a method by utilizing it within two distinct applications: (a) for optimizing placement 
of the sensor electrode within a nanochannel device for overlapping the pre-concentration 
and sensor regions during the electrochemical detection of neuropeptide Y (NPY), a 
biomarker for stress; and (b) for quantifying the polarizability dispersion of silica nano-
colloids by accounting for the field non-uniformities across the pre-concentration zone 
through weighting pixels in the ROI based on their geometric location from the force field 
driving the pre-concentration. In this manner, we are able to quantify the pre-
concentration dynamics and the DEP force dispersion under both, positive and negative 
DEP. Given the ability of this image analysis methodology for automation, with no 
dependence on the pre-concentration position, profile or extent, we envision its universal 
utility in quantifying pre-concentration dynamics over 2D images, as well as from 3D Z-
stack data acquired by confocal microscopy. 
Methods 
A. Device geometry for pre-concentration 
Dielectrophoresis was conducted within an electrode-less device geometry, with 
external Pt electrodes (Alfa Aesar) that were driven using a function generator (Agilent 
33220 A) and a voltage amplifier[59]  for generating applied fields of ~300 Vpp/cm over a 
10 kHz to 5 MHz frequency range, with sharp dielectric constrictions to create localized 
high field points for enabling DEP pre-concentration of polarized particles at the 
constriction tips by pDEP or away from constriction tips by nDEP. In this manner, 
fluorescently labeled NPY biomarkers (Phoenix) were pre-concentrated in PBS media (150 
mM NaCl and 2 mM NaN3) at pH 7.2 and m ~ 1.6 S/m, using AC fields in the 1-3 MHz range 
within a quartz nanochannel (200 nm depth) away from constrictions (30 m to 30 nm 
over 3 m extent). Silica nano-colloids (Corpuscular Inc., Cold Spring, NY; 80 nm sized) 
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were pre-concentrated in 0.1x PBS media (m ~ 0.1 S/m) in the 100 kHz – 2 MHz range 
using constrictions (1 mm to 1 m over a 10 µm length extent) patterned on PDMS (poly-
di-methyl-siloxane) channels (7 m depth) .  The micro/nanofabricated device was bonded 
onto cover slip glass for imaging using an inverted microscope (Zeiss Observer A1) and an 
EMCCD camera (Hamamatsu). For the electrochemical detection of NPY, graphene-
modified glassy carbon electrodes were patterned on the cover slip and bonded to the 
channel after alignment to the pre-concentration region[20], based on procedures 
described herein to quantify pre-concentration dynamics. To enhance particle 
accumulation under nDEP, a small DC offset (0.5-1 V/cm) was applied to the AC field (300 
Vpp/cm). As per the schematic in Figure 5, electro-osmosis (EO) under the DC field 
dominates at all points within the device except in the vicinity of the constriction, where 
nDEP dominates. Upon the balancing of EO with nDEP, particle accumulation occurs on one 
side of the constriction, with no accumulation on the other side, since nDEP and EO are in 
the same direction. The degree of pre-concentration of biomarkers is quantified by ratio of 
intensity enhancement over the background. 
 
FIG. 5: Force balance under electro-
osmosis (EO) versus negative 
dielectrophoresis at the insulator 
constriction (nDEP) causes pre-
concentration of particles over a 
delocalized region of the microfluidic 
device geometry. The position of the 
inner arc, i.e.  (i) vs. (ii) is 
determined by the force balance of 
nDEP and EO, with higher nDEP 
pushing the arc further from the  
constriction tip. The position of the outer arc is determined by the flux balance that includes diffusion. 
Fluorescence images of pre-concentration (greyscale) overlayed with equi-field lines (red lines) shows pre-
concentration over a spread of field lines (one order of magnitude variation) under nDEP with EO. 
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B. Dynamic determination of the region of interest (ROI) 
Prior methods for quantifying pre-concentration dynamics were based on 
monitoring the time evolution of the cumulative or averaged florescence intensity of each 
pixel within a pre-defined ROI. This ROI, which is usually centered on the region with the 
highest pre-concentration, remains static irrespective of the time point of the image or 
alterations to the force field that cause the pre-concentration. The passive nature of this 
ROI determination method can cause errors in determination of the pre-concentration 
level, due to either signal underestimation caused by exclusion of the full extent of pre-
concentration or overestimation caused by inclusion of background intensity levels from 
regions that do not experience pre-concentration. Figure 6 highlights this issue by 
presenting two cases: (i) an ROI chosen to cover the pre-concentration zone, including all 
of the collected time points (large ROI as in Figure 6d); and (ii) an ROI that is centered only 
on the region at a particular time point with the highest sample enrichment (small ROI as in 
Figure 6b). Since the pre-concentration zone tends to begin within a small region and 
gradually expand over time, the application of the large ROI of method (i) to measure 
enrichment level based on average pixel intensity within the ROI will lead to 
underestimation of the pre-concentration level and rate at the early time points, due to 
inclusion of pixels from regions not experiencing pre-concentration. On the other hand, if 
the pre-concentration level is quantified by summing the pixel intensities over the ROI, 
then the large ROI of method (i) will lead to overestimation of pre-concentration level at 
the early time points due to inclusion of pixel intensity from the background regions that 
do not experience pre-concentration. While this problem can be mitigated by using a 
background removal step to zero out the pixel intensity within the regions lacking pre-
concentration, such an operation would make it difficult to detect particle depletion.  
Similarly, the small ROI of method (ii) will lead to overestimation of the pre-
concentration level if the signal averaging method is used, whereas it will lead to 
underestimation of pre-concentration level if the cumulative signal method is used, due to 
exclusion of some regions from the total signal.  
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FIG. 6: (a) Comparing static methods for determination of region of interest (ROI) with dynamic methods for 
quantifying the pre-concentration from fluorescence signal levels. ROI based on the blue box inside the pre-
concentration zone (b) versus the red box that surrounds the entire possible pre-concentration zone (d), is 
compared to the green curve that dynamically detects the boundaries of the pre-concentration region versus 
the background (c). 
C. Particle distribution statistics to determine signal and background thresholds 
The criteria for setting the minimum and maximum threshold pixel intensity levels for 
determining sample pre-concentration and depletion, respectively, are described here. 
Since typical experiments to optimize pre-concentration levels are often performed under 
differing initial conditions, such as the starting particle concentration level, fluorescent 
labels of differing quantum efficiency, and variations in the intensity of the light source 
used for excitation, the threshold levels may need to be redefined for each experiment. 
Hence, we begin by delineating the background measured in a background region of 
interest (BROI), wherein the concentration of sample particles is uniform and not affected 
by pre-concentration or depletion, as shown in Figure 6a for our particular device 
geometry. The background intensity distribution will either be measured initially and 
remain constant through the duration of the pre-concentration experiment, or be 
continuously computed for each time point and/or varying force field. Accurate 
measurement of the background intensity can be challenging within some microfluidic 
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device geometries, such as due to delocalized pre-concentration zones or overlapping pre-
concentration and depletion regions, which can introduce substantial errors. In such 
situations, an ideal BROI is chosen to be in a region that is far enough from the pre-
concentration zone, so that it is not affected by particle enrichment. In this background 
region, we can assume that particles are uniformly distributed in the media and 
consequently the light intensity distribution follows a normal distribution for which the 
mean intensity is defined as μ and the standard deviation is defined as σ.  In such regions, 
only 2% of pixels should have intensity levels higher than two times the standard 
deviations above the mean intensity level: μ+2σ. If more than 2% of pixels in the BROI have 
intensity levels greater than μ+2σ or lower than μ-2σ, then it indicates that some portion of 
this BROI is experiencing either depletion or pre-concentration. Hence, the size of BROI is 
reduced row-by-row or column-by-column, starting from the side of the BROI that is 
closest to the likely pre-concentration region. After each reduction in size, the pixel 
intensity distribution is again measured and the process is repeated until the above 
criterion is satisfied. In this manner, the background region can be unequivocally assigned 
in an automated manner for each pre-concentration time point and force field variation. 
Once the background distribution has been delineated, it may be used to define threshold 
intensities for depletion and enrichment (Figure 6b).  
 
FIG. 6: (a) Defining the background region of interest (BROI) for measuring background intensity. (b) 
Normalized pixel intensity distribution in BROI and criterion for setting intensity threshold levels to detect 
pixels undergoing pre-concentration or depletion to determine the net pixel intensity distribution; (c) 
Dynamic determination of region of interest for quantifying pre-concentration. Light intensities are 
converted from a 16 bit scale to a scale of: 0-1. 
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Again, assuming the background light intensity distribution follows a normal 
distribution, there is a 98% chance that pixels with intensity levels greater than μ+2σ are 
experiencing particle enrichment, thereby delineating the threshold level for pre-
concentration. In order to prevent false positives, our image analysis method labels a 
particular pixel as undergoing pre-concentration, only if one or more of its neighboring 
pixels are also above the threshold level. Similarly, since only 2% of pixels have intensity 
levels lower than twice the standard deviation below the mean intensity: μ-2σ, we 
delineate this as the threshold level for depletion. Using these thresholds, we can quantify 
the degree of pre-concentration or depletion of each pixel through intensity measurements. 
D. Computation of pre-concentration over 2D areas and 3D stacks 
Based on these threshold levels, an ROI of similar shape and extent as the pre-
concentration zone can be dynamically defined (Figure 6c). Unlike the static ROI used in 
prior work, the dynamic ROI can adapt its shape, position and extent based upon 
alterations in the pre-concentration zone at different time points or under varying force 
fields, thereby enabling a more accurate computation of the cumulative and average pixel 
intensity at each time point of the pre-concentration. This dynamic method also allows for 
spatially characterizing the pre-concentration and depletion zones for computation of the 
rate of growth, direction of growth, and deviations from the previously defined ROI. 
Furthermore, it provides information on the statistics of particle distribution within the 
pre-concentration zone, which can be applied towards the design for localization of the 
sensor for particle detection. The threshold levels can also be defined based on sensitivity 
levels of a particular detection scheme to couple pre-concentration with detection. This 
dynamic method also enables accurate quantification of pre-concentration over a three 
dimensional volume. Images collected from a set of 3D z-stack images can be analyzed 
individually, each with its unique ROI, thereby allowing for accurate analysis of variations 
in the z direction. This would not be possible with a static ROI, since the varying shape, 
position and extent of the pre-concentration over the Z-stacks would lead to substantial 
error. 
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E. Application towards aligning preconcentration and detection regions 
We illustrate the relevance of this image analysis methodology for quantifying pre-
concentration dynamics, by utilizing it to ensure optimal alignment of the electrochemical 
detection electrode for NPY biomarkers to its pre-concentration region under the nDEP 
force balance, which exhibits significant changes in shape and position over time. Figure 7a 
shows the highly delocalized pre-concentration profile of positively charged NPY under the 
electrokinetic force balance.  
The image analysis methodology is utilized to quantify the position and shape of the 
regions that exhibit intensity enhancements up to 15x over the background. In fact, as per 
the time evolution of the intensity profiles in Figure 7c and 7d, the highest intensity region 
changes significantly in position and shape over the pre-concentration time, beginning 
close to the channel walls and evolving gradually towards the device centerline. 
 
FIG. 7: Alignment of the graphene-modified electrode in the nanochannel based on spatio-temporal dynamics 
of NPY pre-concentration: (a) fluorescence image of NPY pre-concentration; (b) spatial spread of intensity 
enhancements over the active device region; (c) & (d) time evolution of pre-concentration region; (e) 
alignment of sensor electrode over the pre-concentration region for reducing diffusion lengths of pre-
concentrated analytes. 
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In this manner, the edge position and width of graphene-modified glassy carbon 
electrodes patterned on the cover slip can be aligned to the constriction tip of the 
microfluidic channel prior to device bonding. This ensures effective coupling of NPY pre-
concentration to electrochemical detection, as per Figure 7e, for covering the region with at 
least 10x intensity enhancements. Significant deviations in electrode alignment from this 
optimized position would reduce the binding kinetics of pre-concentrated NPY biomarkers 
on the sensor, thereby lowering signal from electroactive tyrosine groups, while the 
electrode area outside the pre-concentration region contributes to capacitive background 
without signal enhancement. In this manner, by utilizing this methodology to determine 
alignment of detection electrodes within the nanochannel of a constriction device, we have 
demonstrated the detection of neuropeptides at picomolar levels within a few seconds[20].    
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1.3. Frequency-selective enrichment of biomolecules in physiological 
media based on electrical double-layer induced polarization 
Introduction 
Biomolecular assays require the quantitative identification of trace levels of biomarkers 
within bio-fluids that also contain common interfering species, such as circulating 
antibodies, at million to billion-fold higher concentrations. Circulating human antibodies 
with receptor sites for animal proteins that arise upon exposure to particular antigens (so-
called human anti-animal antibodies) have been recognized as a major source of 
interference to analyte detection using two-site or sandwich immunoassays[60],[4]. 
Specifically for the case of immunoassays for prostate specific antigen (PSA), human anti-
mouse antibodies (HAMA) of immunoglobulins (IgG) can cause false positives, leading to 
misdiagnosis and overtreatment of patients[61],[62]. HAMA within serum can vary widely 
from g/mL to g/mL levels, and can persist in blood for several months after antigen 
exposure. For the purpose of gauging post-operative cancer remission, PSA needs to be 
detected at sub-ng/mL levels[63]. Hence, the presence of PSA at nearly million to billion-
fold lower levels than interfering HAMA species can lead to significant quantification 
errors, even at sub-1% interference levels. Current strategies to reduce interferences[64] 
include assay redesign, introduction of chemical modifications to HAMA and suppressing 
the patient’s immune system. These approaches limit versatility of the immunoassay by 
requiring additional incubation steps and enhancing their costs due to the need for 
additional reagents, while their effectiveness is limited by the wide variations in HAMA 
levels within typical patients. An alternate strategy is to cause rapid and selective 
enrichment of the biomarker versus the interfering species[1], preferably within 
physiological media, to maintain its binding ability with receptors, without needing buffer 
changes that lead to dilution. Since antibody-based affinity methods that deplete the 
biomarker of interest cause only slow and mild levels of enrichment[2]; there is a need for 
complementary enrichment modalities.  
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Electrokinetic methods within nanochannels are commonly investigated for achieving 
highly enriched analyte plugs from dilute samples. Typically, a force balance under DC 
electrokinetics is coupled with the enhanced field arising from localized ion depletion in 
nanochannels to cause high degrees of biomarker enrichment[7]. However, due to the 
abrupt field profile, the trapped biomarkers are co-localized within a tightly confined 
region especially for molecules of like-charge, which limits the scope for selectivity based 
on spatially graded stacking. In this work, we instead utilize the frequency-selective 
features of AC electrokinetics, since the electrical double-layer around the biomolecule 
exhibits a characteristic time constant for surface conductance induced polarization. 
Specifically, the average distance required for surface conduction to induce biomolecular 
polarization differs based on its size and shape, while the sharp dependence of surface 
conductance on zeta potential of the biomolecule affects the magnitude of polarization. 
Selective translation of particles occurs by dielectrophoresis (DEP) due to the 
characteristic frequency response of dielectric permittivity of the particle versus the 
medium[11],[12],[13],[14], which has been widely applied towards enriching m-scale 
colloids. While DEP has been recently applied to the enrichment of nanoscale bio-colloids, 
such as ss-DNA[18],[16],[17] and proteins in physiological media[18],[19],[20],[21], there 
are no instances of its application in a frequency-selective manner towards biomarker 
enrichment and detection. The mechanistic basis of our work draws upon prior work[65] 
on sub-micron scale colloids within media of low conductivity, wherein colloidal size and 
surface charge characteristically alter the time constant for surface conduction in their 
electrical double-layer, thereby influencing dispersion of positive dielectrophoresis (pDEP). 
However, since we seek to selectively enrich and simultaneously bind proteomic 
biomolecules to receptors for enabling detection versus interfering species, we work 
within physiologically relevant media of high conductivity, wherein negative 
dielectrophoresis (nDEP) effects are highly significant. Hence, we focus instead surface 
conduction-induced alterations to the nDEP dispersion. Using DC-offset AC fields, these 
nDEP differences at the characteristic frequency of interest are balanced versus 
electrophoresis within nanochannels[66],[67], to cause rapid and selective biomarker 
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enrichment versus interfering species. Based on prior work on PSA enrichment for 
speeding immunoassays[21], we enrich PSA with the necessary frequency-selectivity for 
reducing signal interferences on the immunoassay from circulating antibodies. 
Results and discussion 
A. Physical basis for selective enrichment: Polarized molecules are represented as 
spherical colloids of radius ‘a’ within a media of permittivity: m, experiencing 
dielectrophoretic behavior under an electric field (E) with a spatially varying gradient 
(E), caused by a trapping force (FDEP) given by: 
𝐹 𝐷𝐸𝑃 = 2πa
3𝜀𝑚𝑅𝑒 [
𝜀𝑝
′ ∗−𝜀𝑚
∗
𝜀𝑝
′ ∗+ 2𝜀𝑚
∗
 
]
⏟     
𝐾𝑖(𝜔)  
 |E|∇|𝐸|       (15) 
Here, 𝐾𝑖(𝜔) is the frequency-dependent complex polarizability of the particle that 
depends on the complex permittivity of the medium (𝜀𝑚
∗) and effective permittivity of the 
particle (𝜀𝑝
′ ∗). The respective complex permittivities (𝜀∗) are defined in terms of dielectric 
permittivity (𝜀) and conductivity (σ): 
𝜀∗ = 𝜀 − 𝑗𝜎/𝜔           (16) 
The effective complex permittivity of the colloid (𝜀𝑝
′ ∗) is computed using a simplified 
dielectric model, wherein it is represented by an insulating core (core & core) of radius: a, 
surrounded by a conductive ionic double-layer (DL & DL) of thickness: 𝜅−1 and surface 
conductance: Ks, within media of relatively high conductivity (m & m), as per Figure 8. 
 
 
 
 
FIG 8: Simplified dielectric model to compute effective 
permittivity (𝜀𝑝
′ ∗) of biomolecule is based on an insulating 
core (c & c) of radius: a, surrounded by a conductive ion 
cloud formed by the double-layer (DL & DL) of thickness: 
𝜅−1. 
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Based on Eq. (16), polarization of the composite nanocolloid (𝐾𝑖(𝜔)) is determined at 
high frequencies (> 10 MHz) by the respective permittivity values: (𝜀𝑝
′ − 𝜀𝑚)/(𝜀𝑝
′ + 2𝜀𝑚), 
whereas at lower frequencies (<10 MHz) it is determined by the respective conductivity 
values: (𝜎𝑝
′ − 𝜎𝑚)/(𝜎𝑝
′ + 2𝜎𝑚). Due to the low net conductivity and permittivity levels of 
the colloid, we anticipate nDEP behavior or negative 𝐾𝑖(𝜔) values within conductive 
physiological media, since  𝜎𝑝
′ < 𝜎𝑚 and 𝜀𝑝
′ < 𝜀𝑚. Hence, within the schematic of Figure 9 
that qualitatively describes the polarization dispersion versus colloid size, the nDEP 
behavior at high frequencies is represented (Fig 9a-9d) as medium-induced polarization 
anti-parallel to the applied field (𝑝  ↑↓  ?⃗? ), which is independent of particle size. At lower 
frequencies, the net particle conductivity (𝜎𝑝
′ ) is chiefly determined by surface conductance 
(Ks) within the electrical double-layer of nanostructures, since Ks/a can greatly exceed the 
conductivity of the particle core (𝜎𝑐), as per simplification: 
𝜎𝑝
′ = 𝜎𝑐 + 𝜎𝐷𝐿 = 𝜎𝑐 +
𝐾𝑆
𝑎
          (17) 
As a result, the ion cloud around the particle can polarize parallel to the applied field 
(𝑝  ↑↑  ?⃗? ), thereby causing pDEP. This is especially apparent within smaller sized 
nanostructures (Fig. 9e vs. 9f), wherein the pDEP bandwidth is greater. 
The polarization dispersion can be quantitatively computed using the simplified 
dielectric model in Figure 8, to compute the effective complex permittivity of the colloid 
(𝜀𝑝
′ ∗) in terms of the dielectric properties of the insulating core and conducting double-
layer, with the ratio of external (core plus double layer) to internal (core) radius 
represented by ‘𝛾’. 
𝜀𝑝
′ ∗ = 𝜀𝑑𝑙 (
𝛾3+2(
𝜀𝑐𝑜𝑟𝑒
∗−𝜀𝑑𝑙
∗
𝜀𝑐𝑜𝑟𝑒
∗+2𝜀𝑑𝑙
∗ 
)
𝛾3−(
𝜀𝑐𝑜𝑟𝑒∗−𝜀𝑑𝑙
∗
𝜀𝑐𝑜𝑟𝑒
∗+2𝜀𝑑𝑙
∗ 
)
)        (18) 
As explained previously, the conductivity and permittivity of the core are insignificant 
versus the respective properties of the double layer. Hence, we focus on computing the 
represents the dielectric properties of the double layer (𝜀𝑑𝑙
∗): 
𝜀𝑑𝑙
∗ = 𝜀𝑑𝑙 +
𝜎𝑑𝑙
𝑗𝜔
          (19) 
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FIG 9: (a-d) At high frequencies or early time periods, nanocolloids are polarized anti-parallel to the field 
(𝑝  ↑↓  ?⃗? ), for small as well as large sized colloids. At lower frequencies (e-h), wherein sufficient time is 
available for surface conductance in the double-layer (red and blue arrows), the polarization on 
nanocolloids can be flipped parallel to the field (𝑝  ↑↑  ?⃗? ). This time constant () can differ for small versus 
large colloids (e vs. f) due to differences in average distance for surface conduction induced double-layer 
polarization. 
For the DEP frequencies less than 10 MHz, it is reasonable to assume that DL does not 
vary too strongly with frequency, suggesting that the frequency variations arise chiefly due 
to DL. As per Figure 9, the effectiveness of surface conduction in the double-layer to flip the 
polarization direction on the net dipole (from: 𝑝  ↑↓  ?⃗?  to 𝑝  ↑↑  ?⃗? ) depends on the ability of 
ions within the double layer to traverse the full distance around the particle surface within 
the half cycle of the electric field frequency. Consequently, surface conduction-induced 
flipping is highly effective at low frequencies (sufficient time for conduction) and at smaller 
colloidal size. The frequency dispersion of double layer conductivity is given by[14]: 
𝜎𝑑𝑙 = (
2𝑘𝑠
𝑎
) (1 +
𝜔𝜏
1+𝜔2𝜏2
)         (20) 
The time constant () required for surface conduction in the double-layer to flip the net 
polarization falls sharply (a2) with colloidal size, as given by[14]: 
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𝜏 =
2𝜋(𝑎+𝜅−1)
2
𝐷
           (21) 
Here, D is the diffusion coefficient and -1 is the ionic strength-dependent length of the 
electrical double-layer. Hence, the polarization direction on smaller nanocolloids can be 
flipped to: 𝑝  ↑↑  ?⃗?  (Fig. 9e) at earlier time periods versus on larger nanocolloids (Fig. 9f: 
𝑝  ↑↓  ?⃗? ), due to the lower distance required for surface conductance-induced polarization 
of smaller particles. Along similar lines, the net polarization dispersion also depends on the 
shape of the colloid, since deviations from the spherical shape will cause its polarization to 
no longer be the same across all directions[12]. This directional influence of polarizability 
affects the so-called depolarization factor: 𝐴𝑖 , where 𝑖 =  𝑥, 𝑦, 𝑧; which is the ratio of the 
internal electric field induced by charges on the surface of a dielectric under external field 
to its net polarization (see Supporting Information). The computed polarization dispersion 
in Figure 10 shows pDEP at low frequencies, due to dominance of surface conduction; i.e. 
𝐾𝑠
𝑎
− 𝜎𝑚 > 0. With increasing frequency, the effectiveness of surface conduction drops, 
thereby lowering pDEP polarization with frequency (Eq. (19)). Eventually, nDEP behavior 
is reached (
𝐾𝑠
𝑎
− 𝜎𝑚 < 0), with the transition determined by the time constant for 
polarization () of Eq. (20). At even higher frequencies, wherein permittivity differences 
dominate the polarization behavior, the small difference in permittivity of the double-layer 
around the colloid (DL) versus permittivity of the media (m) causes weaker levels of nDEP 
than observed due to the conductivity differences in the mid-frequency range. 
The variation to the polarization dispersion induced by alteration of colloidal size is 
shown in Figure 11a, while that induced by surface conduction alterations for similar 
colloidal size, such as would occur for colloids of differing surface charge is computed in 
Figure 11b. Smaller colloidal size significantly lowers the polarization time constant () due 
to the quadratic dependence of  on hydrodynamic radius (a), which can be observed as an 
upshifting in the crossover frequency. 
Also, due to the highly effective surface conduction within colloids of smaller size, the 
overall bandwidth of the region wherein conductivity effects dominate over permittivity 
effects is enhanced. This means that the DL-driven weak nDEP behavior is pushed to higher 
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frequencies for smaller colloids. On the other hand, surface charge of the colloid influences 
the net polarization dispersion due to the sharp hyperbolic cosine dependence of surface 
conductance (Ks) on its zeta potential (ξ)[14]. As a result, the higher surface conduction 
raises the pDEP level and its bandwidth, while inhibiting the nDEP level at higher 
frequencies (Fig. 11b). In summary, these simulations of the polarization dispersion 
suggest that particle size and shape dictate the frequency for onset of nDEP (based on their 
sharp effect on ), whereas higher surface charge (i.e. higher Ks/a for same a values) 
inhibits the nDEP level. 
 
Fig. 10: Computed polarization 
dispersion (Real [𝐾𝑖(𝜔) ]) shows 
pDEP at low frequencies due to 
high surface conduction in the 
double-layer, whereas less 
effective surface conduction at 
frequencies above the inverse time 
constant () leads to nDEP, 
especially within media of high m. 
At even higher frequencies, the 
small differences between DL and 
m lead to weak nDEP behaviour. 
(Simulation conditions: Ks= 0.457 
nS; core=0.01 S/m; D=210-9 m2/s; 
-1=2 nm) 
B. Influence of device geometry on force field: Next we review the device geometry 
that is used to create the force balance towards causing enrichment of the nanocolloids. For 
the work presented here on biomolecules, we use the device structure as per Figure 12, 
wherein field non-uniformities are initiated within a set of nanoslits with lateral 
constructions based on an AC field offset by DC voltage applied to electrodes within the 
reservoir that lead to the microchannel and nanoslits. 
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FIG. 11: Computed polarization dispersion for varying: (a) size; and (b) surface conduction represented as: 
Ks/a. (Simulation conditions similar to Fig. 10) 
Based on this geometry, the net enrichment of negatively charged biomolecules in 
physiological media occurs in the nanoslit along the cathodic region away from the lateral 
constriction. We choose to utilize the enrichment under nDEP rather than that under pDEP, 
since the DC-offset nDEP profile is sufficiently delocalized to enable facile alignment of a 
sensor surface immobilized with receptors for capture of the target. 
Also, pDEP is less likely within the physiological media used to capture target 
molecules. Enrichment occurs due to the force balance of nDEP versus electrophoresis 
(EP): 
𝐹𝑛𝑒𝑡 = 𝐹𝐸𝑃 − 𝐹𝑛𝐷𝐸𝑃         (22) 
Here, Fnet denotes the net force causing the enrichment, under FnDEP (given by Eq. (15)) 
and FEP that is given by: 
𝐹𝐸𝑃 = 6𝜋𝜂𝑎𝜇𝐸;  𝑤ℎ𝑒𝑟𝑒𝑖𝑛 𝜇 =
2𝜀𝜁
3𝜂
       (23) 
Here, 𝜇 is the electrophoretic mobility that is dependent on zeta potential (𝜁) and viscosity 
(). Hence, while colloidal size affects the respective magnitudes of FnDEP and FEP, the 
difference in enrichment levels between two molecules of differing sizes (𝐹𝑛𝑒𝑡
1  vs. 𝐹𝑛𝑒𝑡
2 ) is 
less strongly dependent on colloidal size and more strongly dependent on the differences 
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in spatial profiles of FnDEP vs. FEP. For instance, FEP dominates over much of the nano-slit 
region, except in the immediate vicinity of lateral constriction, wherein FnDEP dominates. 
Due to the highly localized spatial profile of nDEP, the enrichment initiation boundary 
within the nanoslit (Fig. 12) is determined by FEP. Hence, biomolecules with lower FEP 
exhibit an enrichment initiation boundary that is further away from the lateral constriction 
and the enrichment is more spread-outwards, whereas for molecules with higher 
electrophoretic mobility, the enrichment initiates closer to the lateral constriction and 
forms over a relatively narrow band, due to the exponential drop in FnDEP away from the 
constriction. 
 
FIG. 12: Biomolecular enrichment (negative charged) occurs inside the nanoslit within the cathodic interface 
of the constriction due to a force balance of nDEP (green arrows) versus EP or electrophoresis (red arrow). 
C. Surface conduction induced polarization time constant 
We validate the influence of colloidal size and surface charge on surface conduction in 
the double-layer by studying the polarization time constant of silica nanocolloids. 
Specifically, differing colloidal size and surface charge alters the surface conduction in the 
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double-layer, thereby altering the crossover frequency from pDEP to nDEP, due to flipping 
of the net dipole. In this case, the device geometry shows lateral insulator constrictions of 1 
m gap (Fig. 13a), with the indicated positions for pDEP (Fig. 13b) and nDEP enrichment 
(Fig. 13c).  
 
FIG. 13: (a) Lateral insulator constriction and schematic enrichment profile under: (b) pDEP; (c) nDEP (EK 
denotes DC-electrokinetics);. Frequency-dependent DEP after 20s for: (d, e & f) small (a=40 nm) versus (d, f & 
h) large (a=55 nm) colloids at ξ=-40 mV versus (j, k & l) ξ=-55 mV. Scale bar=4 m and ξ potential in brackets. 
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At low frequencies (100 kHz), surface conduction in the double-layer has sufficient 
time to polarize the nanocolloid in the field direction, thereby exhibiting pDEP behavior for 
all types of nanocolloids (Fig. 13d, 13g & 13j). At higher frequencies (500 kHz), while 
smaller nanocolloids (a=40 nm) continue to exhibit polarization parallel to the field, as 
evident from the weak pDEP behavior, the surface conduction on larger nanocolloids (a=55 
nm) is insufficient to induce polarization, thereby causing nDEP. However, for the case of 
larger nanocolloids (a=55 nm) with a significantly higher zeta potential (ξ=-55 mV) that is 
created by carboxyl functional groups, the pDEP behavior continues to be apparent at 500 
kHz. At 1 MHz, the insufficient time for surface conduction drives all of three nanocolloid-
types to nDEP behavior. However, the larger nanocolloid (a=55 nm) with the higher zeta 
potential (ξ=-55 mV) shows the weakest nDEP behavior of all three nanocolloid-types, 
consistent with the computed inhibition of the nDEP behavior with increasing surface 
conduction (Fig. 11b). Hence, enhanced surface conduction on smaller colloids up-shifts the 
frequency for nDEP onset, while higher surface charge on colloids inhibits the nDEP level. 
D. Frequency-selective enrichment molecular biomarkers 
Next, we utilize the frequency selectivity offered by this polarization method to cause 
selective enrichment of the biomarker of interest, namely PSA (Fig. 14(i)) versus 
circulating antibodies of anti-mouse immunoglobulin (IgG) (Fig. 14(ii)), in the 0.8-6 MHz 
range. The fluorescence intensities for varying frequency conditions of nDEP induced 
electrokinetic trapping are determined by averaging the maximum intensities from 20 
pixels across the image and normalizing these levels to those obtained under purely DC 
fields, where no perceptible rise in fluorescence is apparent. 
These IgG type antibodies interfere with analyte detection using sandwich 
immunoassays, by causing false positives. While the IgG antibody (~150 kDa) is 
significantly larger than free PSA (33 kDa), it is composed of various heavy (~50 kDa) and 
light (~25 kDa) peptide fragments that are comparable in size to serum PSA present within 
its free and bound forms (~90 kDa). Given these different forms of the biomolecules in the 
body, there is a need for enrichment methods other than size-based filtration. Additionally, 
we seek to enrich and detect the smaller molecule i.e. PSA, versus the larger interfering 
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molecule (anti-mouse IgG), which is not easily accomplished by standard separation 
techniques.  
 
FIG. 14: Frequency-dependence of nDEP enrichment of PSA versus anti-mouse IgG in the 0.8-6 MHz range in a 
nanoslit device with lateral constrictions (dashed line). Scale bar is 10 m. 
Figure 14 shows that PSA enrichment under nDEP requires AC-fields of 4-6 MHz, whereas 
anti-mouse IgG antibodies show only weak levels of enrichment in 0.8-1.2 MHz, with no 
enrichment beyond 2 MHz. Based on the simulations of polarization dispersion of 
nanocolloids in Figure 11, we infer that the time constant for surface conduction induced 
double-layer polarization is significantly higher for the larger anti-mouse IgG species 
versus smaller PSA molecules, thereby leading to nDEP onset at lower frequencies versus 
that for the case of smaller PSA molecules. This is also consistent with the observations in 
Figure 13 showing that rapid double-layer polarization of smaller nanocolloids leads to 
nDEP behavior only at higher frequencies. 
Furthermore, the open Y-shaped structure of IgG species, with their highly charged groups 
likely enables significantly higher levels of surface charge versus that for the coiled 
structure of PSA. Hence, the enhanced surface conductance likely inhibits nDEP levels, 
consistent with the simulations in Figure 11b and the observations for the high zeta 
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potential nanocolloids (Fig. 13l versus 13i). With PSA molecules, on the other hand, while 
nDEP onset requires higher frequencies (few MHz) due to the lower double-layer 
polarization time-constant for smaller molecules (Eq. 20), the nDEP level is not inhibited). 
Also, the higher surface charge on the anti-mouse IgG species leads to higher EP and FEP, 
based on Eq. 22. The higher FEP versus FnDEP over much of the nanoslit region limits IgG 
enrichment to the immediate vicinity of the constriction (Fig. 14(ii)), wherein FnDEP 
becomes significant. On the other hand, the lower surface charge and FEP on PSA molecules 
enable enrichment over a wider region, as per the image of Figure 14(i), since FnDEP is 
comparable to FEP over a greater region of the nanoslit. All of this explains the selective-
enrichment of PSA in the 4-6 MHz range, wherein anti-mouse IgG is not enriched. 
 
FIG 15. (a) Anti-mouse immunoglobulin (IgG) antibodies cause false positives to PSA immunoassay, as per the 
electron transfer schematics shown in the inset (assay details in reference[21]). In absence of nDEP 
enrichment in the nanoslit, signals from 50 pg/mL of PSA are almost two-fold higher in presence of 1 g/mL 
IgG, whereas with nDEP enrichment, these false positives are insignificant. (b) Signal versus time shows rapid 
enhancement in binding kinetics of PSA, causing near steady-state signals within 2 minutes under surface 
conduction enhanced nDEP enrichment. 
E. Eliminating false-positives on PSA immunoassay 
Based on the selective enrichment characteristics of PSA versus interfering anti-mouse 
IgG antibodies under nDEP enrichment within the nanoslit at 6 MHz, we demonstrate its 
coupling to immobilized receptors on graphene-modified surfaces to study the false 
positives within immunoassays. Electron transfer schematics for the electrochemical 
detection platform for PSA and pathway by which the anti-mouse IgG antibody interferes 
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with the sandwich immunoassay are shown in the inset of Figure 15a. As per 
voltammograms in Figure 15a, in the absence of nDEP enrichment inside the nanoslit 
device, a significant level of false positive signal due to immunoassay interference is 
observed within a few minutes of binding. With nDEP enrichment inside the nanoslit 
device, no significant difference is observed between the immunoassay with just 50 pg/mL 
PSA versus that with an additional level (2104-fold higher levels) of interfering anti-
mouse IgG antibodies. The kinetic plot in Figure 11b shows that steady-state signals can be 
reached within 2 minutes of binding under nDEP enrichment of PSA, whereas in the 
absence of nDEP enrichment the signal does not reach a steady-state level, presumably due 
to anti-mouse IgG induced non-specific binding that causes false positives[68]. 
F. Experimental Methods 
Details of the device geometry and operation are available in prior work[21],[66] and 
in Supporting Information. Briefly, four reservoirs lead to a microchannel of 5 m depth 
and several nanoslits of 200 nm depth, 30 m width and 300 m length. Within each 
nanoslit, a sharp lateral constriction is used to create spatial non-uniformities in the field. 
All experiments were conducted in a supporting electrolyte of phosphate buffer saline 
(PBS; 0.1 M, pH 7) of ~1.6 S/m conductivity. Glassy carbon modified Pt electrodes were 
used to apply an AC field of 70 Vrms/cm in the 1-6 MHz range, with a 1.5 VDC/cm offset field 
to localize the nDEP enrichment. The data described herein is shown in the vicinity of the 
constriction region. Biomarkers were procured as follows: Alexa 488 labeled Goat anti-
mouse IgG antibody (~150kDa) from Invitrogen / Thermo Fisher Scientific, Dylight 594 
labeled Prostate Specific Antigen (~30 kDa) from Sigma Aldrich (St. Louis, MO) and silica 
nano-colloids (Corpuscular Inc., Cold Spring, NY). Method for altering surface charge on 
nanocolloids. The nDEP enrichment is coupled to the PSA immunoassay immobilized on 
graphene and gold nanoparticle-modified working electrodes, alongside reference and 
counter electrodes for voltammetric detection. The PSA antibody immobilized on the 
detection electrode was orthogonally aligned to the nDEP enrichment region. The sandwich 
assay uses Alkaline phosphatase (ALP) tagged to secondary PSA antibody for selective 
catalysis of -naphthyl phosphate (NPP) to the electroactive -naphthol (NP) product (see 
detection scheme in inset of Fig. 4a). Square-wave voltammetric (SWV) scans of α-NP were 
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performed in PBS media by scanning from 0.1 to 0.4 VDC, using a 100 Hz frequency; 4 mV 
step potential; and 25 mV AC amplitude. Standard deviations () were based on three 
different electrochemical measurements at each time point. 
Conclusion 
In the first part of this chapter we introduced a methodology based on AC 
electrokinetics for initiating frequency-selective and ultrafast enrichment of biomarkers 
within physiological media inside nanoslit devices. Using AC fields to generate negative 
dielectrophoresis and an offset DC field to initiate ion concentration polarization at surface 
charge non-uniformities in the nanoslit, the localized field intensity is enhanced due to ion 
depletion and the field gradient is enhanced due to ion accumulation, thereby enabling 
biomarker enrichment in physiological media. The optimal device geometry for creating 
the charge non-uniformity inside the nanoslit is a sharp lateral constriction with a gap of 
~40 nm and a length of ~300 nm, to enable an extension of the ion depletion region from 
the anodic interface up to the cathodic interface. As a result, ultrafast electrokinetic 
enrichment of biomarkers occurs within physiological media due to the highly focused 
trapping profile, whereas the trapping profiles are more dispersed within media of lower 
bulk conductivity, due to the lowered biomarker nDEP alongside the enhanced level of 
disruptions from electro-osmotic flow. Using a conservative estimate for the surface charge 
non-uniformity (c= −0.08 𝐶𝑚−2), the ICP-induced enhancement in the potential barrier 
for electrokinetic trapping within physiological media (m=1.6 S/m) is ~5-fold higher than 
in the absence of ICP. Using a Boltzmann distribution for biomarkers, this suggests >100x 
higher levels of enrichment than obtained solely under nDEP, as validated by experimental 
observations. Finally, since this AC electrokinetic methodology causes ultrafast biomarker 
enrichment in conductive physiological media, wherein DC electrokinetic enrichment is 
limited, we envision its application for biomarker discovery, protein crystallization and in 
biosensing for speeding assay kinetics and reducing interferences. 
In the second part of this chapter we presented a dynamic methodology for defining 
the region of interest towards quantifying the pre-concentration dynamics of fluorescently 
labeled biomarkers over delocalized zones, as obtained under a balance of varying force 
fields. Unlike prior methods based on a statically defined region of interest, our method 
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uses a statistical description of particle distribution across the device geometry to 
determine threshold intensity levels for pre-concentration and depletion, thereby 
dynamically defining the region of interest. This automated methodology is applied to 
study the pre-concentration dynamics of Neuropeptide Y biomarkers and silica nano-
colloids under an electrokinetic force balance, driven by negative dielectrophoresis from 
insulating constriction tips, which causes a highly delocalized pre-concentration zone. The 
spatio-temporal evolution of the preconcentration dynamics is used to optimize alignment 
of the electrochemical detection electrode to the region with a threshold preconcentration 
level, to enhance analyte-binding kinetics to the sensor.  
In the third part of this chapter we used our developed platform to enable frequency-
selective enrichment of molecular biomarkers within physiological media. Size differences 
between biomolecules alter their time constant for surface conduction-induced double-
layer polarization, thereby tuning the onset frequency for nDEP, whereas surface charge 
differences between biomolecules alter the opposing electrophoretic force field, thereby 
modulating enrichment levels. In this manner, we show the frequency-selective enrichment 
of PSA versus anti-mouse IgG antibodies in the 4-6 MHz range. By coupling enrichment to 
voltammetric detection using immobilized receptors on graphene-modified surfaces, we 
show that the false positives usually obtained with >104-fold higher levels of interfering 
anti-mouse IgG antibodies can be eliminated. Based on the rapid and selective biomarker 
enrichment characteristics of this AC electrokinetic methodology in conductive 
physiological media, we envision its application for biomarker discovery, protein 
crystallization and for speeding bio-assay kinetics and reducing interferences. 
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Predictive analytics platform for studying 
cancer and neurodegenerative diseases by 
probing mitochondrial morphological 
patterns as a new biomarker 
2 
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Recent years have seen an explosion in the amount of genetic, proteomic and 
metabolomic information available for a wide variety of human tumors and cancer cell 
lines.  This information can be used to associate various patient outcomes with specific 
genetic aberrations and to potentially guide therapeutic decisions.  However, specific 
genetic, proteomic and metabolic states can often interact in complex and unpredictable 
ways to alter cellular phenotypes and these phenotypes are what ultimately drive the 
tumorigenic process.  To that end, it is important that we begin to amass phenotypic data 
on a large number of human tumor samples so that we can (1) determine the relationship 
between the genetic, proteomic and metabolic state of the tumor cells with the key 
phenotypes that drive tumor growth, and (2) begin to understand the relationship between 
particular cellular phenotypes and patient outcomes. This approach is especially significant 
for optimizing therapeutic strategies, since current therapeutic approaches benefit only a 
subgroup of cancer patients due to both genetic and phenotypic heterogeneity of the 
tumors. Herein, we develop a machine learning based technique to predict certain 
proteomic outcomes based on phenotypic and morphological heterogeneity of 
mitochondrial networks within cells, which we envision as a new biomarker to inform 
therapeutic strategies. To achieve this goal, we developed a robust image processing 
methodology to quantify mitochondrial networks and extract different measured 
properties from them. 
In the second part of this chapter, in an attempt to better understand the role of alterations 
in mitochondrial dynamics within several pathological conditions, identifying therapies 
that target aberrant regulation of the mitochondrial dynamics machinery, and 
characterizing the regulating signaling pathways, we aimed at developing a label-free 
means to quantify the dynamic alterations in mitochondrial morphology.  In particular we 
examine the ability of conductivity alterations to the cell interior as a label-free method to 
track intracellular mitochondrial modifications, based on benchmarking mitochondrial 
features using label-based image analysis. This method is validated using independent 
mitochondrial modification methods that are carried out on two different cell lines, namely 
human embryonic kidney cells and mouse embryonic fibroblasts. In both cell lines, the 
inhibition of mitochondrial fission that leads to a mitochondrial structure of higher 
connectivity is shown to substantially enhance conductivity of the cell interior, as apparent 
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from the significantly higher positive dielectrophoresis levels in the 0.5-15 MHz range. 
Using single-cell velocity tracking, we show ~10-fold higher positive dielectrophoresis 
levels at 0.5 MHz for cells with a highly connected versus those with a highly fragmented 
mitochondrial structure, suggesting the feasibility for frequency-selective dielectrophoretic 
isolation of cells to aid the discovery process for development of therapeutics targeting the 
mitochondrial machinery. 
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2.1. Predictive analytics platform for studying cancer and 
neurodegenerative diseases by probing mitochondrial morphological 
patterns as a new biomarker 
Introduction 
Mitochondria are double membrane organelles in eukaryotic cells that are highly 
dynamic and primarily responsible for meeting the energy requirements of the cell[69-71]. 
An important requirement for proper mitochondrial function is a tightly regulated 
mitochondrial morphology, which is characterized by continuous cycles of fusion and 
fission. Aberrant regulation of mitochondrial machinery is associated with a number of 
human diseases, including Parkinson’s disease, Alzheimer’s disease and diabetes[71], as 
well as serving as a classic “hallmarks” of human cancer[72], including apoptosis, 
proliferation, autophagy and metabolism. All of this underscores the need for means to 
characterize mitochondrial morphology and utilize its quantitative characteristics to 
selectively collect or bin cells for understanding the underlying molecular mechanisms and 
developing novel therapeutics that utilize this tumor-specific phenomenon.  
Pancreatic cancer is the fourth causes of cancer-related deaths for men and women in the 
United States, which also has the lowest 5-year survival of any cancer. One third of human 
tumors and up to 90% of pancreatic tumors harbor mutations in the Ras genes. The 
activation of Ras or MAPK is shown to promote mitochondrial fission through 
phosphorylation of the fission GTPase Drp1[73]. Activation of the Ras-MAPK (mitogen-
activated protein kinase) pathway promotes phosphorylation of the mitochondrial fission 
GTPase Drp1 (dynamin-related protein 1), which subsequently induces mitochondrial 
fission. On the other hand, mitofusin proteins 1 and 2 (MFN1/2) on the outer 
mitochondrial membrane are responsible for reversing the mitochondrial fission 
pathway[74]. In recent work[75], our collaborators (Kashatus et al) demonstrated that 
mitochondrial fission was required for tumor growth in a xenograft model of pancreatic 
cancer, since its inhibition through shRNA-mediated knockdown of Drp1 was shown to 
block tumor growth. It has also been shown that mitochondrial fission promotes 
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maintenance of stem cells in glioma and that inhibition of Drp1-dependent mitochondrial 
fission can effectively block tumor growth in a mouse model of gliomagenesis[76]. Despite 
the wealth of data linking mitochondrial fission to tumor growth, the discovery of 
therapeutics targeting the mitochondrial machinery has been limited. One reason is the 
lack of methodologies capable of quantitatively distinguishing phenotypic differences in 
mitochondrial morphology and relating them to their genetic heterogeneity, which 
impedes systematic investigation of the role of mitochondrial dynamics in tumor 
development. This requires data analysis techniques that step beyond single cell 
phenotypes to techniques that can decipher patterns between clusters of data sets. Hence, 
there is a need for means to characterize mitochondrial morphology at different levels and 
utilize its quantitative characteristics to selectively collect or bin cells for understanding 
the underlying molecular mechanisms that regulate the morphology and developing novel 
therapeutics that utilize this disease-specific phenomenon. 
In recent years there is a huge interest in developing image analysis methodologies for 
morphological evaluation of mitochondrial network. Most of these methods utilize high-
content fluorescence microscopy to evaluate mitochondrial morphology evaluation[77-82]. 
However, since most of prior methods treat all types of mitochondria as similar objects, 
they lack the ability to detect subtle changes in interconnectedness of mitochondrial 
network, and are not well suited towards quantifying the different mitochondrial 
morphological shapes that occur much less frequently than others within the 
mitochondrial networks. 
To overcome the limitations of current methodologies, we developed an image analysis 
routine (MyMiA Project) to quantify key features of mitochondrial morphology, such as 
branch-level and cell-level measurements that can be utilized to compute the 
connectedness due to mitochondrial morphologies. Next, we developed and utilized a 
robust machine learning approach (Sibyl Project) to leverage the rich mitochondrial data 
produced by MyMiA and the extensive physiological, metabolomic, transcriptomic and 
other data generated by two relevant mouse models of pancreatic cancer: A well-validated, 
tractable and inducible genetically engineered model of pancreatic ductal adenocarcinoma 
that recapitulates the full progression of the human disease and a robust and biologically 
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relevant orthotopic mouse model using patient-derived pancreatic tumors that faithfully 
models the full heterogeneity of the human disease. Sibyl project aims at correlating 
mitochondrial patterns across various tumor subtypes to metabolomic profiles through 
supervised learning routines and identifying morphological patterns between cells with 
similar physiological traits by using statistical analysis and unsupervised learning methods.  
 
FIG 1.  Inhibition of Drp1 reverses Ras-induced mitochondrial fragmentation and blocks tumor growth. A. 
Mitochondrial morphology of HEK-TtH cells transiently expressing HRasG12V in the presence or absence of 
Drp1 shRNA. B. HEK-TtH cells stably expressing HRasG12V and either scramble (u) or Drp1 shRNA (n) were 
injected into immuno-compromised mice and tumor volume was determined on indicated days post-injection 
(p-value for day 17).[73]  
All the mouse models and related experiments were conducted in “Kashatus Lab” in 
department of immunology and cancer biology at University of Virginia’s School of 
Medicine by their lab students and staff. The image analysis and microfluidics work was 
conducted in the “Swami Lab”. 
Cell lines and imaging 
A. Cell Lines 
Generation of HEK cells expressing HRasG12V plus Drp1 shRNA or shScramble control 
are  described in detail in the previous work by Kashatus. et.al [75]. Mouse embryonic 
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fibroblasts (MEFs) with Mfn1/2 knockout (MfnKO MEFs) were purchased from American 
Type Culture Collection (ATCC).  To generate Drp1 knockout MEFs, Drp1flox/flox mice[83] 
were bred to TP53flox/flox mice[84].  MEFs were generated from Drp1flox/flox; TP53flox/flox 
embryos and subsequently infected with adeno-associated-CMV-Cre-GFP (AAV-CMV-Cre-
GFP, University of North Carolina at Chapel Hill Vector Core). Single cell clones were 
isolated and recombination of both alleles of Drp1 and p53 was confirmed by PCR. 
In order to determine the requirement of Drp1-mediated mitochondrial fission for 
pancreatic cancer growth, we proposed to cross Drp1flox/flox mice36 with LSL-KrasG12D/+; 
Trp53flox/flox; Pdx-1-CreERTg/+ mice, resulting in mice in which intraperitoneal (i.p.) injection 
of tamoxifen (TM) would lead to expression active KRasG12D and deletion of p53 and Drp1 
in adult pancreatic cells. In this model, inducible expression of oncogenic KRas and loss of 
p53 causes a high percentage of mice to develop an invasive and poorly differentiated 
pancreatic ductal adenocarcinoma that closely recapitulates the clinical and pathological 
features of the human disease. 
B. Cell imaging for analysis of mitochondrial morphology 
The described HEK and MEF cell lines were plated on glass microslides a day prior to 
visualization of their mitochondria by one of the following methods: (1) Cells were fixed, 
permeabilized and incubated with -Tom20 primary antibody (Santa Cruz Biotechnology) 
in conjunction with an -rabbit Alexa-488 secondary antibody (Life Technologies); (2) 
Cells were engineered to stably express mitochondria-targeted YFP[85] (BD Biosciences). A 
Zeiss LSM 700 confocal microscope with 63X oil objective was used for imaging.  
Methods 
A. Image analysis methodology to quantify mitochondrial connectivity (MyMiA) 
The panel of cell lines isolated from our tumor model exhibits a range of Drp1 
expression levels that ultimately result in a range of mitochondrial morphologies. To 
quantify different mitochondrial topological structures in these cells, we developed an 
image analysis platform, MyMiA, which uses color separation and shape detection 
methodologies on the stained cell images to segment the cell nucleus, membrane and its 
mitochondrial network. Then the skeleton of mitochondrial network in each cell is 
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extracted and mapped to the original network to enable characterization and quantification 
of that mitochondrial network of each cell. Image analysis pipeline is composed of several 
steps, as discussed below. Figure 2 shows the image-processing pipeline in MyMiA.  
Image preparation 
i. Color separation and object detection 
Different stains are used for fluorescence labeling of different structures in the cells 
(nucleus, mitochondria, membrane). In order to analyze the structure of mitochondrial 
network both in intercellular and intra cellular scopes, first it required to distinguish and 
separate each structure from one another. To achieve an automated separation and 
identification of cell structures there should be no pre-assumption on colors used for each 
structure. To identify the colors used for staining the different structures in the cells, an 
unsupervised machine learning algorithm, Mean-shift clustering algorithms are used to 
identify the colors used for staining, as shown in Figure 3(1). 
 
Figure 2. Image processing pipeline in MyMiA 
After color separation, to identify each structural element of the cell, as shown in figure 
3(2), a simple decision tree is used to classify each element into its object group, (nucleus, 
mitochondria, membrane) based on its structural features. (Nucleus is big and round, 
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membrane is big, and has low surface to perimeter ratio, mitochondria are small, and/or 
have tree like structure). 
ii. Pre-processing  
For high accuracy characterization of mitochondrial networks, high quality and noise-
free images are essential. However most of microscopy images usually suffer from different 
sources of noise, such as uneven illumination and presence of dim, out-of-plane objects. 
Consequently, preprocessing is vital for accurate analysis of the images, and is one of the 
essential parts of images-processing pipeline in MyMiA. 
First, a Median filter is used as a de-noising tool to deal with some of aforementioned 
sources of noise. The size of filter should be chosen meticulously. It should be large enough 
to remove the noise inside mitochondrial network, while preventing blurring at the 
edges[80]. Width of the mitochondria, as its smallest feature, can be a good measure for the 
size of this filter.  
In the second step a “top hat” filter[86] is applied to the image, to remove non-uniform 
background from the image. This step is crucial for creating a high quality binary mask of 
the mitochondrial network, and its segmentation. To further remove the noise, an adaptive 
noise-removal Wiener filter is used. Since this filter can tailor itself to the local image 
variance (little smoothing in large variance, and vice versa), it well preserves the edges. 
In the third step of pre-processing, a median filter is applied, followed by intensity 
normalization. This step is necessary to avoid any possible noise after applying the top hat 
filter, and also eliminating unwanted smoothing effects of previously applied filters.  
After this three-step process, a binary mask of mitochondrial network is created using 
the Bradley adaptive thresholding. The idea behind this is that one global threshold does 
not work well for detecting and detaching the objects of interest from their underlying 
background, since the background intensity is not same at different areas of an image. 
Local adaptive thresholding uses different thresholds to separate similar objects 
(mitochondrial network, nucleus) from background at different regions of the image. 
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FIG 3. Mitochondrial network quantification process flowchart. 
 
Object segmentation 
The second stage of the image-processing pipeline in MyMiA is segmenting different 
objects, such as nucleus and mitochondria in the cell.  
i. Nucleus 
In order to segment the nucleus another step of pre-processing is required. First the 
relevant color channel is selected. Next, a large smoothing Gaussian filter is applied to 
reduce the intensity variation inside nucleus. Then size filtering is used to correctly choose 
the nucleus as the largest element in that specific color channel. MyMiA keeps track of each 
nucleus and its features, such as size and shape and saves them for the next step of the 
analysis. 
ii. Mitochondria 
Identifying individual branches in mitochondrial network is a multi-step process with 
the following steps: (i) selecting the relevant color channel. (ii) using a thinning process to 
create the skeleton of the mitochondrial network from it binary mask. (iii) finding all 
mitochondria and their respective branches, branch points and end points in the 
mitochondrial network and keeping track of each of them. (iv) creating mitochondrial 
boundary and individual branch (within each mitochondrion) masks and mapping to the 
original image to find the properties of each individual branch. (v) finding different 
properties of each mitochondrion, such as area, perimeter, major axis, and minor axis, and 
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also properties of its respective branches, such as length, width, area, angle, etc. and saving 
them for the next step of the analysis.  
One of the unique features of mitochondrial network is its degree of connectedness, 
which is not well defined within prior work. In MyMiA we proposed and use a unique 
methodology to measure the degree of connectedness in mitochondrial network of the cell. 
In each cell we count the total number of branch points and number of branches. 
 
FIG 4. Concept of network components and strength of connection in a component 
Based on this data and considering possible connections in a mitochondrial network, 
we create an ideal network with maximum connectivity, as if all the mitochondria in the 
cell where connected together. Then to compute connectedness, within each individual 
component of our cell (the component which is isolated from other components as shown 
in Figure 8) we define the strength of the connection as: 
Connection strength =  𝐵𝑖𝑛𝑖         (1) 
 𝐵𝑖 is the number of branches in ith  component in the mitochondrial network of the cell, 
and 𝑛𝑖  is the number of branch points in the same component. Then the connectedness of 
the network is defined as the following:  
𝐶𝑓 =
2∑ 𝐵𝑖𝑛𝑖𝑖
((𝐵𝑖𝑑𝑒𝑎𝑙−1)×(𝐵𝑖𝑑𝑒𝑎𝑙−2))+2𝐵𝑖𝑑𝑒𝑎𝑙−2
       (2) 
𝐵𝑖  
𝑛𝑖 
Boundary of 𝑖𝑡ℎ component  
# branches in 𝑖𝑡ℎ component  
# branch points in 𝑖𝑡ℎ component  
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where 𝐵𝑖𝑑𝑒𝑎𝑙 = (∑ 𝑛𝑖𝑖 − (𝑀𝑎𝑥(𝑖) − 1)) is the possible number of branches in a network if 
all components in our cell where connected together to form a fully connected network. 
Target Linking and storing data 
The next step of the analysis is target linking, which links each nucleus, and mitochondrial 
network to its surrounding membrane (or a Region of Interest (ROI) defined by user). As a 
result of this step, properties of each element of that cell, measured in previous steps, are 
linked to that particular cell, thereby assigning every nucleus or mitochondrial network to 
a specific cytoplasmic object. This can be used to compare mitochondrial morphological 
and intensity-based measures across mitochondrial subtypes within individual cells. 
Following this step, all the relevant data are stored in a database and can be exported to be 
used in other data analysis software such as Microsoft excel, or more rigorously with R or 
Python. Figure 5 shows screen shots from different parts of MyMiA software. 
 
FIG 5: Screenshots from MyMiA Image analysis platform. 
Measured quantities by MyMiA 
MyMiA measures 25 different morphological features in each cell including both cell 
level measurements and branch level measurements (See table 1). 
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Cell level measurement Branch level measurement 
Number of mitochondria Connectedness 
Average mitochondria Area Number of Branch Points 
Mitochondria Area STD Number of Branches 
Mitochondria major axis Branch Distribution STD 
Mitochondria minor axis Mean Branch Length 
Polarization degree Branch Length STD 
Extent of mitochondrial network Mean Branch Width 
Mean Distance from nucleus Branch Width STD 
Distribution Skewness Mean Branch Angle 
Distribution Kurtosis  Mean Aspect Ratio 
 Aspect Ratio STD 
 Mean Branch Area 
 Branch Area STD 
 Branch Angle STD 
Table 1: List of morphological features measured by MyMiA, based on the scope of measurement. 
B. Predictive analytics platform for cancer and neurodegenerative diseases studies 
using mitochondrial morphology (Sibyl Project) 
By observing differences in mitochondrial networks we hypothesized that differences 
or combinations of differences in morphological features between different tumor cells are 
correlated to differences in physiological features that drive the tumorigenic phenotype 
within these cells.  To test our hypothesis, we used six cell lines that exhibit a range of 
mitochondrial morphologies and a wealth of phenotypic expression patterns.  With that in 
mind, we used our data to develop a machine-learning classifier that, given the quantified 
mitochondrial features of a cell (using MyMiA), can accurately predict their cell line. Once 
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the system is set up, it can be used to establish correlations between mitochondrial 
morphology and key physiological features (for example: survival…) we have measured for 
these or other cell lines.  Ultimately, this would provide us with testable predictions about 
how specific manipulations of mitochondrial morphology in these cells would alter cell 
physiology and provide a framework for the analysis of tumor cell populations with 
inherent heterogeneity in mitochondrial morphology, rather than that obtained through 
genetic manipulation; with a possibility for utilizing patient-derived tumors and xenografts 
within future iterations. For this analysis, we generated a database of morphological 
features from 1320 different cells, obtained from 6 different cell lines that represent 3 
distinct Drp1 genotypes. 
Data Preparation 
Good data is a pre-requisite of a good model. To improve the performance of our 
machine-learning algorithm we employed multiple pre-processing and data preparation 
steps. 
A. Data exploration 
The first and most important step of the analysis is aimed at understanding the data. 
This step is key to ensure that our data is relevant to the questions we are trying to answer. 
In our case, MyMiA’s data was generated for the purpose of correlating the phenotypic 
features to genotypic and proteomic targets, and since we had all these information 
available for different cells, our data was sufficient to support our analysis. We performed 
some standard data exploration routines like plotting the distribution of values for 
different features, to get a sense of the distribution of the data, and visually inspect for 
outliers in the data. While there was no visual outlier in the data, to be more quantitative, 
for each feature inter-quintile test of outlier detection was used to detect possible outliers, 
but none found in our data set. 
B. Feature engineering 
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As mentioned in the previous section, MyMiA extracts 25 different aggregate features 
of each cell. However along with these set of features, MyMiA generates the vectors of the 
raw data that are used to create these features. This provides a large flexibility to create 
new features based on the need, along the way where they seem necessary. For instance, 
with more experience and visual inspection of images, it seemed that Wriggleness or twist 
of the mitochondria is a feature that can be a good predictor of the cell genotypes, since it 
widely varies among different genetic groups. While this feature was not initially quantified 
by MyMiA, the raw data could be used to create this feature as the following: 
𝑊 = 4𝜋𝐴/𝑃2, Where, A is the area of the mitochondria and P is the perimeter. 
C. Feature selection 
While all extracted mitochondrial features are important to best describe the unique 
mitochondrial network in each individual cell and differentiate it from other cells, not all of 
them are required to predict certain physiologies in the cells. Some mitochondrial features 
may become more highly influenced by a particular cellular process or activity, while not 
changing dramatically with other cellular processes. 
To choose the most relevant set of features to predict the genetic group of the cell, we 
used a recursive back step feature selection. In this approach we started by building a 
model with all the possible features, and then removed the features one by one, to the point 
where removing further features resulted in a big drop in the accuracy of predictions. This 
method proved to be very effective and did not neglect the collinearity of the features as 
shown in Figure 6.  
B. Model Selection and validation 
Our main goal is to develop a set of models that can use mitochondrial morphology 
data to classify cells, with high performance and accuracy, based on an additional defining 
variable such as cell type, genotype, or some relevant physiological readout.  Successful 
generation of these models will allow us both to prospectively predict key physiological 
features of a tumor (eg - likelihood that a tumor will metastasize or respond to treatment) 
and to generate testable hypotheses about the relationship between mitochondrial 
morphology and physiology (eg - connectedness supports lipid metabolism, distance from 
nucleus supports migration and invasion, etc.). 
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FIG 6. Correlation matrix of features. It is clear that there is a strong correlation between some of the features. 
In order to develop this model, our initial approach was to attempt several different 
machine learning models using the data from our six tumor cell lines and train them to 
classify the cells into one of several predefined classes (i.e - classify each cell into one of six 
cell lines or one of three genotypes).  Each potential model was tested using 10-fold cross 
validation.  Briefly, the data were randomly divided into 10 equal portions. One of the 10 
portions was held out as the validation data to later test the performance of the model, 
while the remaining 9 portions were mixed and used to train the system.  At the end of this 
stage, performance of the machine-learning model was evaluated by its ability to predict 
the class of the held out sample, which was not used during the training phase.  This 
process was then repeated 9 times (one time for each remaining portion) for each of the 
validations sets, so that each of the 10 portions was only used once for evaluating the 
model’s performance. The average of the 10 performance measures, one from each 
validation set, were then reported for each model. In this method, data from each cell was 
used 9 times for training and only one time for testing, and thus the entire dataset was used 
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for both training and testing the model.  Performance measures were defined as follows, 
where TP=True Positive, TN=True Negative, FP=False Positive and FN=False Negative: 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
                𝑅𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
                𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
Results and conclusion 
We used different classification models for our purpose using the above mentioned 
methodology to classify different cells for different genetic groups and cells lines. Among 
the different classification models tested, Adaptive Boosting (AdaBoost) with decision tree 
solver, was the model with highest accuracy, recall and precision in predicting the cell line 
and the genotype. In brief, AdaBoost combines multiple simple classifiers, with 
performance slightly better than random selection, for improved performance. The output 
is a weighted sum of outputs from different classifiers. Each classifier is tweaked in favor of 
misclassified instances by previous classifiers to further enhance the performance by 
making the mistakes bolder. The base weak learner in our AdaBoost algorithm is decision 
tree, which is a classification method that breaks down the dataset into smaller and smaller 
subsets while simultaneously and incrementally growing an associated decision tree. The 
basis for breaking down data is information gain, i.e. how much does the uncertainty in the 
data decrease if it is split based on one of the features. The goal after the split is to achieve 
the most homogenous set of subsets, i.e. subsets with the most similar values or least 
impurity.  The data are initially split into smaller subsets based on the feature that reduces 
the uncertainty the most. Each of the created subsets is then divided into smaller subsets 
with even more homogeneity. This process is continued on each subset, up to a point where 
further splitting is not possible.  
Application of the optimized AdaBoost algorithm on our set of 1320 analyzed cells, on the 
test set (25% of data) resulted in 80% average accuracy, 79% average precision & 79% 
average recall in predicting the genotype of the cell, where random selection would result 
in 33% (since we had a fairly balanced dataset with equal contribution from each of the 3 
different genotype samples).  Notably, it also predicted the correct cell line with 64% 
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average accuracy, 62% average precision & 62% average recall, where random selection 
would result in 16%. 
In this section, we developed an image-processing platform MyMiA to quantify the 
mitochondrial images, and extract a vector of morphometric features from each cell. This 
valuable set of data could be potentially used to find correlations between phenotype and 
genotype variables in cancers cells to enable us to make predictions about the cell behavior 
based on cell images. We envision this platform and methodology being used in the future 
for even more biologically relevant questions in both the hospital clinic and in basic 
research.  For instance, if we analyzed libraries of healthy and tumor cells stratified by 
tumorgenicity, we may be able to predict clinical measures such as metastatic potential and 
aggressiveness based on mitochondrial features.  This could be used to decrease the need 
for more invasive procedures such as open surgery biopsy needed for many traditional 
histopathology methods and using fine needle aspirate instead to obtain tissue which may 
help diagnose and predict metastatic potential.  In basic research, if we have knowledge 
about a cancer cell’s genetic and metabolic features we can use MyMia to characterize and 
Sybil to predict genetic and metabolic features of newly derived cell lines without 
expensive testing, as well as understand what mitochondrial morphology phenotypes 
result in metabolic changes within the cell.  For instance, due to changes in vascularization 
and oxygen depletion, tumor cells shift their metabolic profile towards glycolysis and away 
from respiration.  Associated mitochondrial morphology changes may be evident as this 
shift occurs, and associated pathways could be targeted in looking at new therapies. 
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2.2. Label-free quantification of alterations in intracellular 
mitochondrial dynamics by monitoring cytoplasmic conductivity 
Introduction 
Mitochondria, which are key regulators of metabolism and cell death within eukaryotic 
cells, undergo constant cycles of fusion and fission, thereby allowing the cell to quickly 
adapt to environmental conditions for promoting cellular health [87],[88],[89]. Mutation 
and aberrant regulation of the mitochondrial fusion and fission machinery is associated 
with a number of human diseases[90],[91],[92], including Parkinson’s disease, Alzheimer’s 
disease and diabetes[93], as well as in physiological processes whose dysregulation are 
classical hallmarks of human cancer[90]. Since increased mitochondrial fission can 
promote glycolysis[94], it has been postulated that tumors may increase mitochondrial 
fission activity to promote the metabolic shifts[95] that create the molecular building 
blocks required for rapid proliferation[96]. Hence, analysis of phenotypes caused by 
mitochondria shaping proteins can help uncover new diagnostic and therapeutic strategies 
for disease states, especially in conjunction with tools that monitor specificity of the 
subcellular alterations. 
Despite the wealth of data linking mitochondrial fission to tumor growth, the discovery 
of therapeutics targeting the mitochondrial machinery has been limited. One reason is a 
lack of robust methods to analyze dynamic changes in mitochondrial morphology. Genetic 
and pharmacological screens are powerful tools to identify novel signaling pathways and 
new inhibitors, but they require unbiased and quantitative readouts. Previous 
quantification attempts based on high content image analysis require stains or markers to 
identify mitochondria and also require the fixing of cells for optimal images[97]. Apart 
from being time-consuming, this methodology cannot easily be applied to non-adherent 
cell types such as immune cells and is not capable of isolating live cell populations based on 
their mitochondrial structure, especially from heterogeneous samples, for downstream 
quantitative analysis. 
In this work, we explore a label-free approach based on cell electrophysiology to 
quantify alterations to mitochondrial structure induced by Drp1 and MFN1/2, which are 
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independently quantified by mitochondrial image analysis of the respective labeled cells. 
Electrophysiology-based methods are of interest since they can characterize the 
mitochondrial alterations, as well as enable frequency-selective dielectrophoretic isolation 
of cells with particular mitochondrial morphology for downstream analysis. 
Dielectrophoresis (DEP) causes the frequency-selective translation of polarized bio-
particles under a spatially non-uniform electric field, either towards the high field region by 
positive DEP (pDEP) for highly polarizable particles versus the media, or away from high 
field region by negative DEP (nDEP) for particles within highly polarizable media[98],[14]. 
The DEP frequency spectra can be fit using a standard shell dielectric model to compute 
conductivity of cell interior[12], which strongly depends on the maximum level of pDEP of 
a cell in the MHz range, at a given media conductivity[99],[100],[101]. Herein, we show a 
significant enhancement in cellular pDEP levels in the 0.5-15 MHz range after genetic 
manipulations that inhibit mitochondrial fission, as validated using independent 
mitochondrial modification methods that are carried out on two different cell lines: Drp1 
knockdown on human embryonic kidney (HEK) cells and Drp1 knockout on mouse 
embryonic fibroblasts (MEFs). Based on this, we infer that significant alterations in 
intracellular mitochondrial structure can be identified and quantified, suggesting feasibility 
for utilizing label-free dielectrophoretic methods to selectively isolate cells based on their 
mitochondrial morphology. 
Methods 
A. Dielectrophoretic spectral measurements 
DEP spectral analysis was performed with unlabeled cells (~106/mL). Prior to the DEP 
experiments, the cell media was replaced with 8.8% sucrose water, with media 
conductivity of 150 ± 5% mS/m, as adjusted by its own culture media. Viability of cells 
within this altered media was verified over a period of one hour, as assessed by trypan blue 
exclusion and by stability of their mitochondrial morphologies by immunofluorescence 
(see Supporting Information). DEP spectral measurements were conducted on a 3DEP 
dielectrophoretic analyzer (DepTech, Uckfield, UK) using a recording interval set to 30 
seconds at 10 Vpp, with data collected over 20 points between 100 kHz to 45 MHz. In this 
3DEP reader, the electric field is applied to gold-plated conducting electrode stripes inside 
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the wall of each well, with the DEP response measured at 20 different frequencies that are 
applied individually within each well. The relative DEP force at each frequency is obtained 
by analyzing spatio-temporal variations in light intensity from particle scattering using 
particular bands in each of the 20 wells, after normalization to the background at zero field 
(time = 0), by accounting for the electric field distribution in the wells[102],[31]. For each 
batch of cells, the relative DEP force at each frequency was obtained using 2 independent 
measurements on the respective cell samples and this process was repeated for 5 separate 
batches of the same cell type to ensure reproducibility, as per the error bars (Figure 10a & 
10c). The maximum pDEP force level in the MHz range for each cell line (HEK and MEFs) 
was used as the basis to normalize all other measured DEP force levels for the respective 
cell line. This approach assumes that the maximum pDEP level for each cell line occurs 
when the cell achieves its maximum polarization level at a particular modification. 
B. Fitting DEP spectra using a multi-shell dielectric model 
In order to discern the particular subcellular regions influenced by the mitochondrial 
alterations carried out herein, the acquired DEP spectra over the 0.1-40 MHz range was fit 
to a standard three-shell or four layer dielectric model of the cell. The layers from cell 
interior to its envelope include: nucleus, nucleus envelope, cytoplasm and cell membrane 
[12] (see Figure 7). 
 
 
 
 
 
 
FIG 7: Geometry of the four-layer dielectric model (each layer with 
permittivity or  and conductivity or ) that is used to fit the DEP spectra, 
including membrane (mem and mem), cytoplasm (cyto and cyto), nucleus 
envelope (NucEnvelope and nucEnvelope), and nucleus (nucleus and nucleus) 
The DEP force (FDEP) on spherical particles is given by: 
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𝐹𝐷𝐸𝑃 = 2𝜋𝜀𝑚𝑅
3𝑅𝑒[𝐾𝑖(𝜔)  ] ∙ ∇(|𝐸|
2)        (1) 
Here, 𝜀𝑚is the permittivity of the medium surrounding the cell, R is the radius of the 
cell, ω is the radian frequency of the applied field, and E is the electric field in the region 
where the cell is located. The Clausius-Mossotti factor (𝐾𝑖(𝜔) ) is a frequency dependent 
measure of cell polarizability determining force direction as: 
𝐾𝑖(𝜔)  = [
𝜀𝑐
′∗−𝜀𝑚
∗
𝜀𝑐
′∗+ 2𝜀𝑚
∗
 
]          (2) 
Here, 𝜀𝑚
∗ and 𝜀𝑐
′∗ are the complex permittivity of the medium and effective permittivity 
of cell respectively. In each case, the complex permittivity depends on the respective 
permittivity (ε) and conductivity (σ) values as per the following frequency dispersion: 
𝜀∗ = 𝜀 + 𝜎 𝑗𝜔⁄            (3) 
 
FIG 8. Methodology used to measure mitochondrial structure through computing a connectedness factor: (a) 
Color channeling on the image of the stained cell followed by a decision tree is used to separate out the 
mitochondrial features the features (b). Pre-processing steps followed by adaptive thresholding is used for 
segmentation of the mitochondrial network to identify individual mitochondria (c), for identifying branches 
(individual mitochondrion) and branch points (mitochondrial joints). Each branch is used as a mask to 
perform measurements such as length, width, area on each individual mitochondrion, so that the 
connectedness factor can be computer (Eq. (6)), as indicated by the red dashed line in (d). 
The effective permittivity of cell (𝜀𝑐
′∗) is calculated in the following iterative manner. 
First, the innermost layer of the cell, i.e. the nucleus, and its surrounding envelope are 
approximated and replaced by a sphere of the same size (nucleus radius plus thickness of 
the nucleus membrane). The effective permittivity is expressed in terms of the respective 
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complex permittivities: 𝜀𝑛𝑢𝑐𝑙𝑒𝑢𝑠
∗ and 𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
∗, while ‘a’ is the ratio of external (nucleus 
plus envelope) to internal (nucleus) radius of the combined layers: 
𝜀𝑁𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
′ ∗ = 𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒 (
𝑎3+2(
𝜀𝑛𝑢𝑐𝑙𝑒𝑢𝑠
∗−𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
∗
𝜀𝑛𝑢𝑐𝑙𝑒𝑢𝑠
∗+2𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
∗ 
)
𝑎3−(
𝜀𝑛𝑢𝑐𝑙𝑒𝑢𝑠
∗−𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
∗
𝜀𝑛𝑢𝑐𝑙𝑒𝑢𝑠
∗+2𝜀𝑛𝑢𝑐𝐸𝑛𝑣𝑒𝑙𝑜𝑝𝑒
∗ 
)
)   (4) 
Next, the same process is repeated until the whole cell is replaced by a single sphere to 
consider the 4 layer spherical model (including nucleus, nucleus envelope, cytoplasm, and 
cytoplasmic membrane). In this manner, the effective permittivity of the nucleus layer in 
Eq. (4), is combined with its surrounding cytoplasm to give effective cytoplasmic 
permittivity and with cell membrane to give effective cell permittivity. Based on this, Eq. 
(2) is used to fit the experimental DEP response of each cell modification. Parameters of the 
closest fit to the data are used to represent dielectric properties of cell elements. 
Results 
A. Images analysis to quantify mitochondrial structure 
In order to separate mitochondrial features from those of the nucleus, we use color 
channeling, since they are differentially stained. This is achieved by maintaining one 
channel with each of RGB colors at a particular time and detecting objects with that specific 
color, followed by a decision tree to separate the features (Fig. 8a versus 8b). Following 
this, multiple pre-processing steps, including median, top-hat, and adaptive wiener filtering 
are applied to remove noise and other imperfections in the image. After pre-processing, an 
adaptive thresholding method is used for segmentation of the mitochondrial network, to 
identify individual mitochondria, as shown in Fig. 2c. This structure is then used to identify 
branches (individual mitochondrion) and branch points (mitochondrial joints). Each 
branch is used as a mask to perform measurements such as length, width, area on each 
individual mitochondrion (Fig. 8c versus Fig. 8d). The connectedness factor (Cf) is a 
measure of connectivity of the mitochondrial network based on its comparison to an ideal 
network, as given by: 
𝐶𝑓 =
2∑ 𝐵𝑖𝑛𝑖𝑖
((𝐵𝑖𝑑𝑒𝑎𝑙−1)×(𝐵𝑖𝑑𝑒𝑎𝑙−2))+2𝐵𝑖𝑑𝑒𝑎𝑙−2
        (6) 
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Here, 𝐵𝑖 is the number of branches in each connected group in the mitochondrial 
network of the cell, with the connected group representing a group of two or more 
mitochondria that are connected together, and 𝑛𝑖  is the number of branch points in the 
same connected group. 𝐵𝑖𝑑𝑒𝑎𝑙: is the number of the branches within the fully connected 
ideal network, as given by: 
𝐵𝑖𝑑𝑒𝑎𝑙 = (∑ 𝑛𝑖𝑖 −𝑀𝑎𝑥(𝑖) − 1)         (7) 
As per the red dashed line in Fig. 8d, the strength of a particular connection for each 
mitochondrial component of the cell is defined as: Bini; where Bi is the number of branches 
in ith component in the mitochondrial network of the cell, and ni is the number of branch 
points in the same component. 
Genetic manipulation of mitochondrial morphology 
HRas is a proto-oncogene whose activation results in many downstream physiological 
changes, including altered metabolism, increased proliferation, blunted apoptosis, and 
changes in gene expression[103]. In order to generate cell lines that exhibit significant 
differences in mitochondrial morphology, but with minimal changes to other aspects of 
cellular physiology, we carried out the following. 
 
FIG 9: Fluoresence images of fixed cells using anti-Tom20-labelling to reveal mitochondrial (green and red for 
HEK and MEFs, respectively) features (nucleus labeled blue). For mitochondrial features, the described image 
analysis method is used to compute the number of branches, branch area (in pixels) and connectedness factor 
as per Eq. (5), as indicated for each cell type. Note that while the respective fixed cells appear to differ in size 
due to well-known interfacial interactions with the substrate, the size variations of suspended cells are 
minimal based on flow cytometry data (Supporting Information section)  
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First, we stably expressed a constitutively active version of HRas called: HRasG12V in 
immortalized HEK cells, which we previously demonstrated to result in a highly 
fragmented mitochondrial network[75].  Next, we stably expressed shRNA targeting either 
Drp1 (HEK-RAS-12V-shDrp) or a scramble control sequence (HEK-RAS-12V-shScramble). 
As expected, shRNA-mediated knockdown of Drp1 results in a complete reversal of the 
mitochondrial fragmentation, indicating an extremely interconnected phenotype (92% 
connectedness, Figure 9(i)). Conversely, expression of the scramble control sequence had 
no effect on the HRas-induced mitochondrial fission, thereby causing these cells to 
maintain a highly fragmented phenotype (25% connectedness, Figure 9(ii)).  Importantly, 
because we are directly targeting the mitochondrial fission machinery (Drp1) in cells that 
start with a fragmented phenotype, this approach allows us to generate two extreme 
mitochondrial phenotypes (i.e. highly fragmented and highly connected) with minimal 
differences in all other aspects of cellular physiology. Furthermore, we compare these 
“extreme” mitochondrial morphologies using a different cell type: mouse embryonic 
fibroblasts (MEFs) generated by a different method, i.e. genetic knockout of the 
mitochondrial fission (Drp1)[83] and fusion (Mfn1/2)[104] machinery, respectively. Since 
Drp1 and MFN1/2 primarily influence mitochondrial dynamics, their deletion should 
induce minimal changes in overall cellular physiology, aside from mitochondrial fission and 
fusion[105]. We generated immortalized Drp1-/- MEFs by infecting cells isolated from 
Drp1flox/flox; TP53flox/flox embryos with adenoviral Cre recombinase. As expected, due 
to their inability to perform mitochondrial fission, these cells exhibit extreme 
mitochondrial connectedness (91% connectedness, Figure 9(iii)). To generate the opposite 
phenotype, we obtained immortalized Mfn1/Mfn2 double knockout cells that are deficient 
in mitochondrial outer membrane fusion[104]. As expected, these MEFs exhibit highly 
fragmented mitochondrial network, due to unopposed mitochondrial fission (17% 
connectedness, Figure 9(iv)). Notably, both sets of MEFs are from the same strain of inbred 
mice (129/Sv) and both are p53 deficient (Mfn1/2-/- MEFs express SV40 Large T-antigen, 
which inhibits p53[106]). Hence, these cells should exhibit minimal changes in overall 
physiology, independent of mitochondrial morphology. In this manner, using two different 
cell types and two separate methods to alter mitochondrial morphology, we envision that 
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the measured alterations to cellular physiology arise solely due to mitochondrial 
phenotype, rather than due to off-target changes associated with our method. 
Mitochondrial phenotype induced DEP alterations 
Modifications to the mitochondrial structure influence cellular physiology, which is 
measured in this work, based on alterations to cytoplasmic electrophysiology. Each 
subcellular region dominates the DEP-induced cell polarizability response over a particular 
frequency range, depending on the contributions of its electrophysiology to the net 
conductivity and permittivity dispersion[107]. Hence, modifications to the mitochondrial 
structure can be selectively probed based on alterations to the DEP frequency response in 
the frequency region wherein the electrophysiology due to mitochondrial structure 
dominates the net polarizability dispersion. It is also noteworthy that a critical level of 
media conductivity (m) is required for optimal distinction of alterations in DEP spectra for 
particular cell types with differing mitochondrial connectedness. For instance, low m 
levels enhance the contrast for discerning alterations in crossover to pDEP behavior due to 
morphological modifications to the cell envelope [108],[109],[110], which influence the 
respective permittivity values. Similarly, as per the spectral simulations and data in 
Supporting Information section, relatively higher m levels that are closer to the 
conductivity of the cytoplasm (cyto) wherein the mitochondria are situated, should enable 
distinctions in mitochondrial phenotype. In this manner, alterations in the bulk cell DEP 
response can be indicative of modifications to mitochondrial features, as long as the 
appropriate m level and DEP frequency range are chosen for these comparisons. Based on 
this, the spectra are measured at m of 0.15 S/m, since it is close to the anticipated range 
for cyto (0.5-1 S/m), while being low enough for pDEP behavior (i.e. cyto > m ). Comparing 
the DEP response of HEK-RAS-12V-shDrp (Fig. 10a(i)) that exhibits a highly connected 
mitochondrial structure to that of HEK-RAS-12V-shScramble (Fig. 10a(ii)) that exhibits 
highly fragmented mitochondria, the chief differences are in the 0.5-15 MHz region, as 
verified by a t-test at each frequency to confirm well-separated mean values at 95% 
significance level.  
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FIG 10. Dielectrophoretic frequency spectra of: (a) oncogenic HRas modified HEK cells expressing Drp1 shRNA 
(i) versus scramble control shRNA (ii); (c) MEFs lacking Drp1 (iii) versus those lacking mitochondrial fusion 
GTPases Mfn1 and Mfn2 (iv). Respective fixed cell images are in Fig. 3. DEP spectra were measured at m of 
0.15 S/m in a 3DEP reader using 20 individual wells with ring electrodes (b) to measure relative DEP force 
levels based on spatio-temporal variations in light scattering, as per example images shown in (d) for nDEP at 
150 kHz, no DEP at 300 kHz and pDEP at 3 MHz field frequencies. 
The DEP well device used to measure these responses is shown in Fig. 10b. Similarly, 
comparing the DEP response of MEF-Drp-KO cells (Fig. 10c(iii)) that exhibit a highly 
connected mitochondrial structure versus MEF-Mfn-KO cells (Fig. 10c(iv)) that exhibit a 
highly fragmented mitochondrial structure, it is apparent that the differences are in the 
0.5-20 MHz region (verified by a t-test at each frequency to confirm separation at 95% 
significance level). It is noteworthy that DEP spectra in the 0.5-15 MHz frequency range are 
dominated by electrophysiology of the cell interior, wherein the mitochondria are situated. 
Hence, the pDEP levels for cells with a highly connected mitochondrial structure are 
consistently higher than those of cells with a highly fragmented mitochondrial structure, 
considering both cell types (HEK and MEFs) and independent of the method used to 
generate the respective mitochondrial phenotype (knockdown versus knockout). Figure 
10d shows some sample images in the DEP-well device that are used to quantify varying 
DEP levels versus frequency, based on the spatio-temporal profiles of light scattering 
induced by DEP motion. Using a three-shell or four-layer dielectric model (Methods 
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section), the respective spectra were fit to obtain dielectric properties for each subcellular 
region of interest (Table 1). 
 
 
Table 1: Fitted dielectric parameters to DEP spectra (details in SI) 
Comparing the fitted dielectric parameters, it is apparent that an enhancement of 
mitochondrial connectivity increases conductivity of the cell interior, as reflected in that of 
the cytoplasm (cyto) and nucleus envelope (nucEnvelope). While Drp1 knockdown in HEK 
cells causes ~70% higher cyto levels and 3-fold higher nucEnvelope levels, Drp1 knockout in 
MEFs causes ~60% higher cyto levels and 3-fold higher nucEnvelope levels. Considering the 
two parameters, the influence of cyto would likely dominate over that of nucEnvelope, since 
cyto is significantly higher (nearly 100-fold higher than nucEnvelope). Hence, increasing cyto 
by 50-70% would substantially increase pDEP levels in the 0.5-15 MHz, whereas a three-
fold rise in the substantially lower conductivity parameter (nucEnvelope), causes only gradual 
alterations to slope of the DEP spectra in the 0.5-2 MHz region, especially at the chosen m 
of 0.15 S/m (>> nucEnvelope). 
Single-cell quantification of pDEP trapping force levels 
The application of DEP towards frequency-selective isolation of cells based on their 
electrophysiology due to a particular mitochondrial structure requires that there be 
significant differences in their trapping force levels at optimal frequencies. While the DEP-
well device measures the force spectra over a wide frequency range (0.1-20 MHz) by 
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quantifying spatio-temporal alterations in light scattering due to the DEP motion of 
particles, it is an indirect method to measure DEP force on particle ensembles, without 
considering the efficacy of trapping forces for the purpose of DEP isolation at a particular 
flow rate. Hence, in order to quantify the differences in pDEP force levels between cells of 
differing mitochondrial structure, we use velocity tracking methods to directly measure 
force levels with single-cell sensitivity. Specifically, we choose an electrode-less DEP device 
configuration (Figure 11a) for these measurements, wherein the electric field is applied 
orthogonal to fluid flow.  
 
 
 
 
 
 
 
 
FIG 11: (a) Microfluidic electrode-less 
dielectrophoresis device using insulating 
posts of PDMS (grey) to enable 
frequency-selective cell trapping, with 
electric field orthogonal to inertial flow. 
(b) Field (100 Vpp/cm, 0.5 MHz in m of 
0.15 S/m) is applied at t-0, shows 
substantial pDEP levels for cells Ras-
expressing HEK cells with shDrp 
modification (1 nN15%) versus with 
Shscramble modification (0.1 nN25%), 
presumably due to their differences 
mitochondrial morphology. 
This device is also significant to assess feasibility for selective cell isolation based on 
mitochondrial structure, since the spatial field non-uniformities created by constrictions 
due to insulating posts can enable frequency-selective isolation of cells at the constriction 
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tips, based on magnitude of their pDEP levels versus orthogonal drag force due to flow. 
Specifically, we choose to compare HRas modified HEK cells expressing shDrp versus those 
expressing a scramble sequence to verify significant differences in pDEP for cells with a 
highly connected versus a highly fragmented mitochondrial structure. While significant 
differences in pDEP levels are obvious for the respective spectra over the 0.5-15 MHz range 
in Fig. 4a, we choose 0.5 MHz for these measurements, since power of the amplifier circuit 
that is used to generate the field over a wide spatial extent degrades at higher frequencies.  
Based on the images in Figure 11b, rapid pDEP trapping is apparent in Figure 11b (i-iii) 
for shDrp-expressing cells with a highly connected mitochondrial structure exhibiting 
pDEP levels of 1 nN  15% based on ten independent single-cell measurements. The 
analogous measurement with HEK cells expressing oncogenic HRasG12V plus a scramble 
control, as per pDEP trapping images in Figure 11b (iv-vi), shows significantly lower pDEP 
levels that are measured at 0.1 nN  25% (based on ten independent single-cell 
measurements). These results based on direct pDEP measurements on single-cells validate 
the spectral distinctions of Figure 10. 
Assuming a steady drop in pDEP force across constriction region of the device, a flow 
rate of ~1.35 L/min is sufficient to ensure that the fluid velocity on the cells is 
significantly higher than the drag force due to FpDEP at the 0.1 nN level, while being lower 
than than the drag force due to FpDEP at the 1 nN level (see Supporting Information for 
device dimensions used in this calculation). Based on this flow rate, a starting 
concentration of 105 cells/mL can be enriched for cells with the higher FpDEP, at a rate of 
~100 cells/min, to enable frequency-selective cell isolation at 0.5 MHz based on the 
cytoplasmic conductivity due to its mitochondrial features. 
Conclusions 
Alterations in connectivity of the intracellular mitochondrial network after select 
genetic modifications are shown to be quantified based on changes in the intracellular 
cytoplasmic conductivity, as determined by fitting dielectrophoretic spectra of the 
respective cells to a standard shell dielectric model. Specifically, direct inhibition of 
mitochondrial fission through shRNA-mediated knockdown of Drp1 increases the 
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cytoplasmic conductivity by ~70% in human embryonic kidney cells and a full genetic 
knockout of Drp1 in mouse embryonic fibroblasts causes a 60% rise in cytoplasmic 
conductivity over cells deficient for mitochondrial fusion. Utilizing a frequency of 0.5 MHz, 
we demonstrate that human embryonic kidney cells with a highly connected mitochondrial 
network exhibit ~10-fold higher trapping forces under positive dielectrophoresis versus 
those with a highly fragmented mitochondrial network. Based on this, we envision a label-
free platform for frequency-selective cell isolation to transform the discovery process, both 
for small molecule modulators of the mitochondrial dynamics machinery and for novel 
signaling pathways that regulate the machinery under a variety of physiological conditions 
[111, 112]. 
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The work presented in this dissertation lays the foundations for developing point-
of-care systems, which enables identifying subjects for optimal therapies based on genetic 
make-up or other molecular or cellular analysis. However it remains a lot to explore using 
these platforms. Nanoslit design, with optimal sensor placement was used to detect PSA 
versus sea of interfering HAMA to enable early detection of prostate cancer in the first 
chapter of this dissertation. However for future work, the same platform can be optimized 
and used to separate biomarkers of different diseases from their interfering species based 
on their different electrical double-layer induced polarization. This detection method can 
be further optimized by using the wave-sequencing methodology that we developed in ref 
109.  
On the mitochondrial morphology analysis in chapter two, we developed a platform 
to identify relationship between mitochondrial morphology and the genotype, as a proof of 
concept to show that morphology of cells can predict different properties of the cells. The 
same platform can be used to establish and identify relationships between morphology and 
number of physiological features important for tumor growth in a similar manner.  These 
physiological features are straightforward to analyze and range from cell-level features to 
tumor-level features, as listed below: 
(i) Mitochondrial features can predict differences in metabolic profile of different 
tumor cell lines. 
(ii) Mitochondrial features present in a primary tumor can predict metastatic potential 
from xenograft models 
(iii) Mitochondrial heterogeneity can predict survival and metastatic potential 
(iv) Mitochondrial features can predict gene expression, mutation status, phospho-RTK 
signaling or cytokine expression 
(v) Mitochondrial network features can predict response to treatment in human patient 
derived xenografts. 
(vi) Accounting for inter-tumoral and intra-tumoral heterogeneity to predict therapies 
based on mitochondrial-shaping proteins 
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